WO2005019378A1 - Mesogenic compounds, medium for electro-optical displays and electro-optical display - Google Patents

Mesogenic compounds, medium for electro-optical displays and electro-optical display Download PDF

Info

Publication number
WO2005019378A1
WO2005019378A1 PCT/EP2004/008942 EP2004008942W WO2005019378A1 WO 2005019378 A1 WO2005019378 A1 WO 2005019378A1 EP 2004008942 W EP2004008942 W EP 2004008942W WO 2005019378 A1 WO2005019378 A1 WO 2005019378A1
Authority
WO
WIPO (PCT)
Prior art keywords
alkyl
independently
alkoxy
halogen
mono
Prior art date
Application number
PCT/EP2004/008942
Other languages
French (fr)
Inventor
Peer Kirsch
Elvira Montenegro
Louise Diane Farrand
Detlef Pauluth
Michael Heckmeier
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Priority to AT04763959T priority Critical patent/ATE447001T1/en
Priority to JP2006524270A priority patent/JP2007503487A/en
Priority to DE602004023857T priority patent/DE602004023857D1/en
Priority to EP04763959A priority patent/EP1658351B1/en
Priority to KR1020067003696A priority patent/KR101198452B1/en
Priority to US10/569,459 priority patent/US7531106B2/en
Publication of WO2005019378A1 publication Critical patent/WO2005019378A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/0403Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit the structure containing one or more specific, optionally substituted ring or ring systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/02Liquid crystal materials characterised by optical, electrical or physical properties of the components, in general
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/10Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/10Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings
    • C09K19/20Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings linked by a chain containing carbon and oxygen atoms as chain links, e.g. esters or ethers
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/0403Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit the structure containing one or more specific, optionally substituted ring or ring systems
    • C09K2019/0407Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit the structure containing one or more specific, optionally substituted ring or ring systems containing a carbocyclic ring, e.g. dicyano-benzene, chlorofluoro-benzene or cyclohexanone
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K2019/0444Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit characterized by a linking chain between rings or ring systems, a bridging chain between extensive mesogenic moieties or an end chain group
    • C09K2019/0466Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit characterized by a linking chain between rings or ring systems, a bridging chain between extensive mesogenic moieties or an end chain group the linking chain being a -CF2O- chain
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2323/00Functional layers of liquid crystal optical display excluding electroactive liquid crystal layer characterised by chemical composition

Definitions

  • the present invention relates to mesogenic compounds, media for electro- optical displays comprising these and to electro-optical displays comprising these media, in particular to displays using mesogenic modulation media which are in an optically isotropic state at the temperature of operation of the light modulation elements and to respective modulation elements and displays.
  • Liquid Crystal Displays are widely used to display information.
  • Electro-optical modes employed are e.g. the twisted nematic (TN)-, the super twisted nematic (STN)- and the electrically controlled birefringence (ECB)-mode with their various modifications, as well as others.
  • TN twisted nematic
  • STN super twisted nematic
  • EBC electrically controlled birefringence
  • electro-optical modes employing an electrical field substantially parallel to the substrates, respectively the liquid crystal layer like e.g. the in-pjane switching (IPS)-mode (compare e.g. DE 40 00 451 and EP 0 588 568).
  • IPS in-pjane switching
  • liquid crystal medium as such, oriented on surfaces, which typically are pre-treated to achieve uniform alignment of the liquid crystal material
  • composite systems of liquid crystal materials of low molecular weight together with polymeric materials such as e.g. p_olymer dispersed liquid crystal (PDLC)-, nematic curvilinearily aligned phase (NCAP)- and polymer network (PN)-systems, as disclosed for example in WO 91/05 029.
  • PDLC p_olymer dispersed liquid crystal
  • NCAP nematic curvilinearily aligned phase
  • PN polymer network
  • LCDs especially LCDs comprising composite systems like PDLCs and in particular so called holographic PDLC (HPDLC) systems are used in practical applications.
  • HPDLCs are described e.g. in Date, Takeuchi, Tanaka, and Kato, Journal of the SID 7/1
  • HPDLC displays are generating three bright colours, preferably primary colors, utilizing Bragg reflection. This technique results in excellent bright colours, as it does neither need polarizers, nor color filters.
  • a single layer of the periodic structure of polymer and liquid crystal controls the reflection of one particular colour. To realise three primary colors consequently three layers, one for each colour are required.
  • Each of the three layers has to be addressed independently. This requires three sets of HPDLC films, each with corresponding electrodes. This large number of layers and corresponding electrodes, which is difficult to realize with a good yield in mass production, can remediiously be reduced when the "two-frequency" drive method is applied.
  • OBC optically compensated bent
  • DE 10252250.2 all yet to be laid open except the first one, describe light controlling elements using modulation media which are in the isotropic state at the operation temperature of the elements, whereas DE 103 13 979.6, also yet to be laid open, describes elements using modulation media which are in the optically isotropic blue phase, when operated.
  • This type of light modulation elements is characterised by very fast response times and by an excellent contrast with minimal viewing angle dependence.
  • the temperature range of operation has not been sufficiently wide so far and the temperature dependence of the operation voltages still is quite high and has to be reduced in order to allow easier addressing over a wider range of temperatures.
  • the compounds should be suitable for use in mesogenic media in electro- optical displays, in particular as control media of these displays.
  • they should be soluble in base media with a mesogenic phase, e.g. a nematic, cholesteric, smectic or even a medium having an optically isotropic phase, e.g. a blue phase.
  • a mesogenic phase e.g. a nematic, cholesteric, smectic
  • a medium having an optically isotropic phase e.g. a blue phase.
  • they even should exhibit one or more of these phases as single compounds.
  • Liquid crystalline or mesogenic compounds with very high values of the dielectric anisotropy so far have mostly (with only very few exceptions) been realised by incorporation of strongly polar terminal groups especially such as a cyano (-CN) group or also a isothiocyanato (-NCS) group as e.g. in EP 01 101 157.
  • a cyano (-CN) group or also a isothiocyanato (-NCS) group as e.g. in EP 01 101 157.
  • Use of compounds of these types leads to mesogenic media, especially for use in TN type displays, with rather low specific resistivity, which in turn do not match the demanding requirements for the voltage holding ratio of the media in displays driven by an active matrix, as e.g.
  • the respective functional or modulation media used for the displays are disclosed in DE 102 17 273 A1.
  • mesogenic media consisting predominantly or even entirely of mesogenic compounds with a terminal fluorine substitution or with a fluorinated terminal group, so far, do not provide a dielectric anisotropy, which is high enough to realise low operation voltages, especially if they are used in light modulation media for the displays disclosed in DE 102 17273 which are most demanding in this respect.
  • mesogenic media with high ⁇ especially useful for displays disclosed in DE 102 17273 A1 and in particular in DE 103 13 979.6 can be realised, which do not exhibit the drawbacks of the materials of the prior art, or at least do exhibit them to a significantly lesser degree.
  • the compounds of the instant invention are particularly well suited for use in light modulation elements and displays using a modulation medium which is in an optically isotropic state, preferably in the blue phase, as disclosed in DE 103 13979.6.
  • the inventive compounds do lead to a significant decrease of the temperature dependence of the characteristic voltages and hence of the operation voltages and/or to a significant increase of the temperature range over which the temperature dependence is rather small.
  • component A a first liquid crystal component comprising compounds of formula I, which are strongly dielectrically positive compounds with very high values of ⁇ and also ⁇ n
  • a, b, c and d are independently of each other 0, 1 or 2, whereby a + b + c + d ⁇ 4;
  • a 11 , A 12 , A 13 and A 14 may be the same ring or two
  • R 11 , R 12 and R 13 independently of each other, are n-alkyl or n-alkoxy with 1 to 20, preferably 1 to 10, preferably 1 to 8, preferably 2 to 8, preferably 2 to 6 C-atoms, alkenyl, alkenyloxy or alkoxyalkyl with 2 to 20, preferably 2 to 8, preferably 2 to 6, preferably 2 to 5 C-atoms or CN, NCS, halogen, preferably F, Cl, halogenated alkyl, alkenyl or alkoxy, preferably mono-, di- or oligo-fluorinated alkyl, alkenyl or alkoxy, especially preferred CF 3 OCF 2 H or OCF 3 , preferably R 11 , R 12 and R 13 are alkoxy, preferably with 1 to 10 C-atoms,
  • one or more of the groups R 11 , L 11 , L 12 , L 13 , L 14 , Y 11 , Y 12 , Y 13 , Y 14 and X 11 which are present in the compounds of formula I, is/are a chiral group, which preferably is a group of formula I * -Q 1 -CH-Q 2 I Q 3 , *
  • Q 1 is an alkylene or alkylene-oxy group with 1 to 9 C atoms or a single bond
  • Q 2 is an alkyl or alkoxy group with 1 to 10 C atoms which may be unsubstituted, mono- or polysubstituted by F, Cl, Br or CN, it being also possible for one or more non-adjacent CH 2 groups to be replaced, in each case independently from one another, by -C ⁇ C-, -0-, -S-, -NH-, -N(CH 3 )-, -CO-, -COO-, -OCO-, -OCO-0-, -S-CO- or -CO-S- in such a manner that oxygen atoms are not linked directly to one another,
  • Q 3 is F, Cl, Br, CN or an alkyl or alkoxy group as defined for Q 2 but being different from Q 2 .
  • the O atom is preferably adjacent to the chiral C atom.
  • Preferred chiral groups of formula I* are 2-alkyl, 2-alkoxy, 2-methylalkyl, 2- methylalkoxy, 2-fluoroalkyl, 2-fluoroalkoxy, 2-(2-ethin)-alkyl, 2-(2-ethin)-alkoxy, 1 ,1 ,1 -trif luoro-2-alkyl and 1 ,1 ,1 -trif luoro-2-alkoxy.
  • achiral branched alkyl group may occasionally be of importance, for example, due to a reduction in the tendency towards crystallization.
  • Branched groups of this type generally do not contain more than one chain branch.
  • At least one and preferably one of the rings A 11 , A 12 , A 13 and A 14 , which are present in the compound of formula 1 is a chiral moiety, preferably selected from the group of cholesterine-diyl, pinimenthol-diyl and tetrahydropyrane-diyl and most preferably tetrahydropyrane-diyl.
  • one or more of the groups R 11 , L 11 , L 12 , L 13 , L 14 , Y 11 , Y 12 , Y 13 , Y 14 and X 11 which are - present in the compounds of formula I, is/are PG-SG wherein SG is a spacer group and
  • PG is a polymerisable or reactive group.
  • the polymerisable or reactive group PG is preferably selected from
  • PG is a vinyl group, an acrylate group, a methacrylate group, an oxetane group or an epoxy group, especially preferably an acrylate or methacrylate group.
  • the spacer group SG all groups can be used that are known for this purpose to those skilled in the art.
  • the spacer group SG is preferably of formula SG'-X, such that PG-SG- is PG-SG'-X-, wherein
  • R 01 , R 02 , Y 01 and Y 02 have one of the respective meanings given above.
  • Typical groups SG' are, for example, -(CH 2 ) P -, -(CH 2 CH 2 0) q -CH 2 CH 2 -, -CH 2 CH 2 -S-CH 2 CH 2 - or -CH 2 CH2-NH-CH 2 CH 2 - or -(SiR°R 00 -O) p -, with p being an integer from 2 to 12, q being an integer from 1 to 3 and R°, R 00 and the other parameters having the meanings given above.
  • Preferred groups SG' are ethylene, propylene, butylene, pentylene, hexylene, heptylene, octylene, nonylene, decylene, undecylene, dodecylene, octadecylene, ethyleneoxyethylene, methyleneoxybutylene, ethylene-thioethylene, ethylene-N-methyl-iminoethylene, 1 -methylalkylene, ethenylene, propenylene and butenylene for example.
  • SG' is a chiral group of formula I*': * 4
  • Q 4 is an alkylene or alkylene-oxy group with 1 to 10 C atoms or a single bond, being different from Q 1 ,
  • each of the two polymerisable groups PG and the two spacer groups SG can be identical or different.
  • a preferred embodiment of the instant are compounds of formula I wherein at one or more, preferably two, three or more, of the radicals
  • R 1 ⁇ L 11 , L 12 , L 13 , L 14 ,Y 1 ⁇ Y 12 , Y 13 , Y 14 and X 11 which are resent, is/are aryl, aryloxy, alkylaryl, alkylaryloxy, alkylarylalkyl, alkylarylalkoxy, cycloalkyl, cycloalkyloxy, cycloalkylalkenyloxy, alkylcycloalkyl, alkylcycloalkyloxy or alkylcycloalkylalkenyloxy, preferably aryloxy, alkylaryloxy, cycloalkyloxy, cycloalkylalkenyloxy, alkylcycloalkyloxy or alkylcycloalkylalkenyloxy, each with up to 15 carbon atoms, wherin said in radicals being unsubstituted or mono- substituted with a -CN group or mono- or poly-substituted with halogen
  • radicals Preferably one or more, preferably two, three or more, of the radicals
  • R x has the meaning given above and preferably is n-alkyl and most preferably methyl.
  • the mesogenic media according to the present invention simultaneously comprise a second mesogenic, liquid crystalline component (called component B), which is a dielectrically positive component comprising, and preferably consisting of terminally polar substituted bi- or terphenyl compounds, which or some of which optionally are laterally fluorinated, preferably of formula II
  • component B is a dielectrically positive component comprising, and preferably consisting of terminally polar substituted bi- or terphenyl compounds, which or some of which optionally are laterally fluorinated, preferably of formula II
  • n 2 is O, 1 , 2 or 3,
  • R ⁇ has the meaning given for R 11 under formula I, preferably under formula 1-1 above, but preferably is alkyl or alkenyl,
  • X 2 is CN, SF 5 , SO2CF3, NCS, CF 3 , OCF 3> F or Cl, preferably CN, NCS or Cl, most preferably CN or NCS.
  • the mesogenic media according to the instant invention contain a component A comprising, preferably predominantly consisting of and most preferably entirely consisting of compounds of formula I.
  • Liquid crystal compounds in this application embrace compounds with a liquid crystalline phase by themselves as well as compounds, which are compatible with mesogenic phases, especially with the nematic phase, without decreasing the clearing point unacceptably.
  • the latter compounds have a mesogenic structure and are also called mesogenic compounds.
  • R, R' and R" independently from each other, are alkyl, alkoxy, alkenyl, alkenyloxy or oxaalkyl, preferably alkoxy, preferably R' and R" and most preferably R, R' and R" are identical to each other, and Y 11 and Y 12 , independently of each other, are as defined hereinbefore.
  • R and X-11 is as defined above and R'" is other, alkyl, alkenyl, alkenyloxy, oxaalkenyl or oxaalkyl. It should be noted that -OR"' radicals having different meanings for R'" can easily be introduced by stepwise
  • R 11 , L 11 , L 12 have the same meaning as given above for general formula I.
  • Comprising in this application means in the context of compositions that the entity referred to, e.g. the medium or the component, contains the compound or compounds in question, preferably in a total concentration of 10 % or more and most preferably of 20 % or more.
  • Predominantly consisting, in this context, means that the entity referred to contains 80 % or more, preferably 90 % or more and most preferably 95 % or more of the compound or compounds in question.
  • Entirely consisting, in this context, means that the entity referred to contains 98 % or more, preferably 99 % or more and most preferably 100.0 % of the compound or compounds in question.
  • the compounds of formula I are preferably selected from the group of sub- formulae 1-1.1 to 1-1.15, especially 1-1.1 , 1-1.2, 1-1.3, 1-1.4 and/or 1-1.5:
  • R 11 to R 13 are identical to each other and preferably are alkoxy, alkenyloxy, halogenated alkoxy or oxaalkoxy, and
  • Y 11 and Y 12 are independently of each other H, CF 3 or F.
  • the compounds of formulae 1-1.1 to 1-1.5 preferably are selected from the group of compounds of formula 1-1 A
  • R, R', R" X, Y 11 and Y 12 are as defined above, preferably
  • X is F, CF 3 , SF 5 , SO 2 CF 3 , OCF3 or CN and
  • Y 11 and Y 12 are independently of each other H, CF 3 or F.
  • liquid crystalline media according to the instant invention contains a component B comprising, preferably predominantly consisting of compounds of formula II as defined hereinbefore.
  • R 2 is alkyl or alkoxy, wherein one or more methylene groups of said alkyl may be replaced -C ⁇ C-, and for sub-formulae lib and lie preferably alkyl.
  • the media according to the present invention may contain a component C.
  • This component C may be dielectrically neutral or dielectrically negative, depending upon the relative amounts of compounds with positive and negative dielectrical anisotropy contained therein.
  • Component C is used in a concentration of 0 to 40 %, preferably 0 to 20 % and most preferably from 0 to 10 % of the total mixture.
  • the inventive liquid crystal medium contains a further component D, which is a dielectrically neutral component and preferably comprises and more preferably consists of dielectrically neutral compounds.
  • Component D is used to adjust especially the phase range and the optical anisotropy of the inventive liquid crystal media.
  • the concentration of component D in the liquid crystal medium according to the present invention is preferably 0 % to 40 %, more preferably 0 % to 25 %, most preferably 0 % to 15 % and in particular 3 to 10 %.
  • the inventive liquid crystal medium contains a further component E, which is a chiral component and preferably comprises and more preferably consists of chiral compounds. It is preferred that the liquid crystal medium according to the invention contains that further chiral component E.
  • the inventive media can comprise further liquid crystal compounds in order to adjust the physical properties.
  • Such compounds are known to the expert.
  • Their concentration in the media according to the instant invention is preferably 0 to 30 %, more preferably 0 to 20 % and most preferably 5 to15 %.
  • the liquid crystal medium contains 50 % to 100 %, more preferably 70 % to 100 % and most preferably 80 % to 100 % and in particular 90 % to 100 % totally of components A and B which contain, preferably predominantly consist of and most preferably entirely consist of one or more of compounds of formulae I and II, respectively.
  • dielectrically positive compounds describes compounds with ⁇ > 1 ,5, dielectrically neutral compounds are compounds with -1 ,5 ⁇ ⁇ ⁇ 1 ,5 and dielectrically negative compounds are compounds with ⁇ ⁇ -1 ,5.
  • is determined at 1 kHz and 20 °C.
  • the dielectrical anisotropies of the compounds is determined from the results of a solution of 10 % of the individual compounds in a nematic host mixture.
  • the capacities of these test mixtures are determined both in a cell with homeotropic and with homogeneous alignment.
  • the cell gap of both types of cells is approximately 10 ⁇ m.
  • the voltage applied is a rectangular wave with a frequency of 1 kHz and a root mean square value typically of 0.1 V or 0.5 V to 1.0 V, however, it is always selected to be below the capacitive threshold of the respective test mixture.
  • the mixture ZLI-4792 and for dielectrically neutral, as well as for dielectrically negative compounds are used as host mixture, respectively.
  • the dielectric permittivities of the compounds are determined from the change of the respective values of the host mixture upon addition of the compounds of interest and are extrapolated to a concentration of the compounds of interest of 100 %.
  • threshold voltage refers in the instant application to the optical threshold and is given for 10 % relative contrast (V- t o) and the term saturation voltage refers to the optical saturation and is given for 90 % relative contrast (Vgo) both, if not explicitly stated otherwise.
  • the capacitive threshold voltage V 0 , also called Freedericks-threshold V Fr ) is only used if explicitly mentioned.
  • the threshold voltages, as well as all other electro- optical properties have been determined with test cells prepared at Merck KGaA, Germany.
  • the test ceils for the determination of ⁇ had a cell gap of 22 ⁇ m.
  • the electrode was a circular ITO electrode with an area of 1.13 cm 2 and a guard ring.
  • the orientation layers were lecithin for homeotropic orientation ( ⁇
  • the capacities were determined with a frequency response analyser Solatron 1260 using a sine wave with a voltage of 0.3 V rms .
  • the light used in the electro-optical measurements was white light.
  • the set up used was a commercially available equipment of Otsuka, Japan.
  • the characteristic voltages have been determined under perpendicular observation.
  • the threshold ( ⁇ o) - mid grey (V 5 o) - and saturation (V 90 ) voltages have been determined for 10 %, 50
  • the liquid crystal media according to the present invention may contain further additives and chiral dopants. It is especially preferred that they contain chiral dopants.
  • the total concentration of these further constituents is in the range of 0 % to 20 %, preferably 0.1 % to 15 %, more preferably 1 to 15 %, especially 1 to 6 %, based in the total mixture.
  • the concentrations of the individual compounds used each are preferably in the range of 0.1 to 3 %. The concentration of these and of similar additives is not taken into consideration for the values and ranges of the concentrations of the liquid crystal components and compounds of the liquid crystal media in this application.
  • the inventive liquid crystal media according to the present invention consist of several compounds, preferably of 3 to 30, more preferably of 5 to 20 and most preferably of 6 to 14 compounds. These compounds are mixed in conventional way. As a rule, the required amount of the compound used in the smaller amount is dissolved in the compound used in the greater amount. In case the temperature is above the clearing point of the compound used in the higher concentration, it is particularly easy to observe completion of the process of dissolution. It is, however, also possible to prepare the media by other conventional ways, e. g. using so called pre-mixtures, which can be e. g. homologous or eutectic mixtures of compounds or using so called multi-bottle-systems, the constituents of which are ready to use mixtures themselves.
  • pre-mixtures which can be e. g. homologous or eutectic mixtures of compounds or using so called multi-bottle-systems, the constituents of which are ready to use mixtures themselves.
  • the liquid crystal media according to the instant invention can be modified in such a way, that they are usable in all known types of liquid crystal displays, either using the liquid crystal media as such, like TN-, TN-AMD, ECB-, VAN-AMD and in particular in composite systems, like PDLC-, NCAP- and PN-LCDs and especially in HPDLCs.
  • the LC media of the present invention are especially suitable for use in light modulation elements and displays using a modulation (or controlling) medium which is in an optically isotropic state, preferably in the blue phase.
  • the melting point T(C,N) or T(C;I), the transition from the smectic (S) to the nematic (N) phase T(S,N) and the clearing poin T(N,l) of the liquid crystals are given in degrees centigrade. ln the present application and especially in the following examples, the structures of the liquid crystal compounds are represented by abbreviations also called acronyms. The transformation of the abbreviations into the corresponding structures is straight forward according to the following two tables A and B. All groups C n H 2n+ ⁇ and
  • the liquid crystal media according to the instant invention do contain preferably four or more compounds selected from the group of compounds of tables A and B and/or five or more compounds selected from the group of compounds of table B and/or two or more compounds selected from the group of compounds of table A.
  • Example 1 the physical data especially of the compounds illustrate to the expert which properties can be achieved in which ranges. Especially the combination of the various properties, which can be preferably achieved, is thus well defined.
  • Example 1 the physical data especially of the compounds illustrate to the expert which properties can be achieved in which ranges. Especially the combination of the various properties, which can be preferably achieved, is thus well defined.
  • the compound is prepared analogously to example 1.
  • the compound has a melting point of 66°C and a melting enthalpy of 7.5 kcal/mol. It is melting from the crystalline glass phase into the isotropic phase.
  • the compound is prepared analogously to example 1.
  • the compound has a glass transition temperature of -23°C, a melting point of 50°C and a melting enthalpy of 6.8 kcal/mol. It is melting from the glass phase into the isotropic phase.
  • the compound has a glass transition temperature of -31 °C. It is melting from the glass phase into the isotropic phase.
  • the compound has a melting point of 16°C, a melting enthalpy of 11.0 kcal/mol and an enthalpy of crystallisation of 3.7 kcal/mol. It is melting from the crystalline phase into the isotropic phase.
  • the compound has a glass transition temperature of -14°C and a melting point of 89°C. It is melting from the glass phase into the isotropic phase.
  • a liquid crystal mixture, host mixture A is realised consisting of:
  • This mixture has the following properties:
  • T g , T (K,l) and T(g,l) given in Tables 1a, 1b below are determined by means of DSC (differential scanning calorimetry) and microscopy.
  • test cell is an electro-optical cell with interdigital electrodes having a distance of electrodes of 10 ⁇ m, a width of electrodes of 10 ⁇ m, and a cell thickness of 10 ⁇ m.
  • the height of the electrodes - that are made out of chromium and without a polyimid layer - can be ignored in comparison to the cell thickness.
  • Ttrans is the characteristic temperature which is defined as follows: - If the characteristic voltage as a function of temperature has a minimum, the temperature at this minimum is denoted as characteristic temperature; - If the characteristic voltage as a function of temperature has no minimum and if the controlling medium has one or more blue phases, the transistion temperature to the blue phase is denoted as characteristic temperature; in case there are more than one blue phase, the lowest transition temperature to a blue phase is denoted as characteristic temperature; - If the characteristic voltage as a function of temperature has no minimum and if the controlling medium has no blue phase, the transistion temperature to the isotropic phase is denoted as characteristic temperature.
  • characteristic voltage refers to a specific voltage, e.g. the threshold voltage V 10 at which a light transmission of 10% is observed or the saturation voltage Vg 0 at which a transmission of 90% is observed.
  • the concentration of the compound of example 47 in the host mixture A is varied from 3% over 5% and 7% to 15%
  • the data are compiled in table 2.
  • Tt r ans. is the transition temperature from the cholesteric phase into the optically isotropic phase. It can be observed in electro-optical cells with cross-polarisers.
  • a liquid crystal mixture, host mixture B, is realised consisting of:
  • This mixture has the following properties:
  • a liquid crystal mixture, host mixture C, is realised consisting of:
  • This mixture has the following properties:
  • a liquid crystal mixture is realised consisting which has the following composition and properties. Table 6
  • a liquid crystal mixture is realised, which has the following composition and properties.
  • a liquid crystal mixture is realised, which has the following composition and properties.
  • a liquid crystal mixture, host mixture D is realised consisting of:
  • This mixture has the following properties:
  • host mixture D now 5% of the compound of example 47 (P(O3) 2 UQU-3O-T), and 5% of the chiral dopant R-5011 and 2% of its enantiomer S-5011 (equivalent to the addition of 3% of R-5011 and 4% of the racemate) are added, as shown in the following table, table 9, and the properties of the resulting mixture are determined. The results are compiled in table 9.
  • a liquid crystal mixture, host mixture E, is realised consisting of:
  • a liquid crystal mixture, host mixture F, is realised consisting of:
  • host mixture F various concentrations of the compound of example 47 (P(O3) 2 UQU-3O-T) and various concentrations of the chiral dopant R-5011 are added and the properties of the resulting mixtures are determined.
  • concentrations and the data are compiled in tables 13a and13b.
  • a liquid crystal mixture, host mixture G is realised consisting of:
  • This mixture has the following properties: Clearing point (T(N,I))/°C: 75.0.
  • host mixture G alternatively 5% (use-example 14.1), 7% (use-example 14.2), and 10% (use-example 14.3), respectively, of the compound of example 47 (P(O3) 2 UQU-3O-T) and 5% of the chiral dopant R-5011 are added and the properties of the resulting mixtures are determined.
  • concentrations and the data are compiled in table 14.
  • host mixtures H to I consisting of:
  • a liquid crystal mixture, host mixture K, is realised consisting of:
  • host mixture K 5% of the compound of example 47 (P(O3) 2 UQU-3O-T) is addded together with 9% of the chiral dopant BO2C*H-C-5 (which is a homologue of S-5011 (also: BO2C*H-C-3) with an n-pentyl terminal chain instead of an n-propyl group and which has an HTP in MLC-6260, available from Merck KGaA, at 20°C of -71.7 ⁇ m "1 ) and the property of the resulting mixture is determined.
  • the results are compiled in table 16.

Abstract

The instant invention relates to liquid crystal media comprising a strongly dielectrically positive component A, comprising one or more compounds of formula (I) wherein the parameters have the meanings given in the text. It also relates to the compounds as such and to mesogenic or liquid crystalline mixtures comprising these compounds.

Description

Mesogenic Compounds, Medium for Electro-optical Displays and Electro-optical Display
Field of the invention
The present invention relates to mesogenic compounds, media for electro- optical displays comprising these and to electro-optical displays comprising these media, in particular to displays using mesogenic modulation media which are in an optically isotropic state at the temperature of operation of the light modulation elements and to respective modulation elements and displays.
Problem to be solved and state of the art
Liquid Crystal Displays (LCDs) are widely used to display information. Electro-optical modes employed are e.g. the twisted nematic (TN)-, the super twisted nematic (STN)- and the electrically controlled birefringence (ECB)-mode with their various modifications, as well as others. Besides these modes, which all do use an electrical field, which is substantially perpendicular to the substrates, respectively to the liquid crystal layer, there are also electro-optical modes employing an electrical field substantially parallel to the substrates, respectively the liquid crystal layer like e.g. the in-pjane switching (IPS)-mode (compare e.g. DE 40 00 451 and EP 0 588 568).
Besides the various different modes using the liquid crystal medium as such, oriented on surfaces, which typically are pre-treated to achieve uniform alignment of the liquid crystal material, there are applications using composite systems of liquid crystal materials of low molecular weight together with polymeric materials such as e.g. p_olymer dispersed liquid crystal (PDLC)-, nematic curvilinearily aligned phase (NCAP)- and polymer network (PN)-systems, as disclosed for example in WO 91/05 029. These composite systems typically use an electrical field substantially perpendicular to the composite layer. LCDs are used for direct view displays, as well as for projection type displays. Besides these applications LCDs, especially LCDs comprising composite systems like PDLCs and in particular so called holographic PDLC (HPDLC) systems are used in practical applications. HPDLCs are described e.g. in Date, Takeuchi, Tanaka, and Kato, Journal of the SID 7/1
(1999), p. 17 to 22, which is incorporated by reference. These HPDLC displays are generating three bright colours, preferably primary colors, utilizing Bragg reflection. This technique results in excellent bright colours, as it does neither need polarizers, nor color filters. A single layer of the periodic structure of polymer and liquid crystal controls the reflection of one particular colour. To realise three primary colors consequently three layers, one for each colour are required. Each of the three layers has to be addressed independently. This requires three sets of HPDLC films, each with corresponding electrodes. This large number of layers and corresponding electrodes, which is difficult to realize with a good yield in mass production, can beneficiously be reduced when the "two-frequency" drive method is applied.
For composite systems a high Δn of the liquid crystal used is required in order to achieve an efficiently scattering state and to realize a good contrast. Though there have been proposed PDLC-systems with liquid crystal mixtures with low Δn to improve the so called off axis haze, the predominant problem in most cases is to achieve sufficient contrast in the first place. This is especially the case for PDLC-systems, which are disclosed e.g. in Date, Takeuchi, Tanaka, and Kanto, Journal of the SID 7/1 (1999), p. 17-22. The liquid crystals available typically are characterized by Δn values of up to 0.280 or even up to 0.29. This upper limit, however, is still insufficiently low for many applications. Further it has so far only been achieved accepting various compromises with respect to the other properties of the liquid crystal mixtures used. The most typical undesired trade-offs are an insufficiently high clearing point, an unfavourably narrow nematic phase range, a rather high temperature for the lower end of the stability of the nematic phase, too low dielectric anisotropy and hence too high operating voltages, unfavourable elastic constants and last not least too high viscosity values or combinations thereof. Good compatibility with the precursors of the polymers of the composite systems and easy phase separation during the formation of the composite systems are obvious prerequisites for liquid crystals for such applications.
Another promising electro-optical mode used in LCDs is the optically compensated bent (OCB) mode. This mode is described e.g. in Yamaguchi et al., "Wide-Viewing-Angle Display Mode for the Active-Matrix LCD Using Bend-Alignment Liquid-Crystal Cell", SID 93, Digest, p. 277 (1993).
This mode is very promising. It is particularly well suited for direct view applications, as it is characterised by a favourable viewing angle dependence. Also the response times are quite short. However for video rate response for the display of changing grey shades the response time still needs to be improved. Compared to a conventional TN display, in an OCB display the amount of deformation of the director is much smaller. Whereas in a TN display the director is oriented almost parallel to the substrates in the non-powered state and changes its direction to almost perpendicular to the substrates upon application of the driving voltage, in an OCB display the director orientation changes to the same final orientation, but it does start from an already almost homeotropic bent starting configuration. Thus, a higher birefringence of the liquid crystal media used is required.
Recently light controlling elements and displays using mesogenic modulation media which are in an optically isotropic state at the temperature of operation of the light modulation elements and to respective modulation elements and display have been described. DE 102 17273 A1 as well as DE 10241 301.0, DE 102 53325.3 and
DE 10252250.2, all yet to be laid open except the first one, describe light controlling elements using modulation media which are in the isotropic state at the operation temperature of the elements, whereas DE 103 13 979.6, also yet to be laid open, describes elements using modulation media which are in the optically isotropic blue phase, when operated. This type of light modulation elements is characterised by very fast response times and by an excellent contrast with minimal viewing angle dependence. However, especially in this novel type of light modulation elements and displays the temperature range of operation has not been sufficiently wide so far and the temperature dependence of the operation voltages still is quite high and has to be reduced in order to allow easier addressing over a wider range of temperatures.
The compounds should be suitable for use in mesogenic media in electro- optical displays, in particular as control media of these displays. For this purpose they should be soluble in base media with a mesogenic phase, e.g. a nematic, cholesteric, smectic or even a medium having an optically isotropic phase, e.g. a blue phase. Preferably they even should exhibit one or more of these phases as single compounds.
These compounds should lead to a decrease of the operation voltages of the corresponding electro-optical displays and of its temperature dependency. Further they should not reduce the voltage holding ratio of the media too much, in order to allow for addressing of the displays by a matrix of active elements with a non-linear electric response characteristic, i.e. in an active matrix display.
Liquid crystalline or mesogenic compounds with very high values of the dielectric anisotropy so far have mostly (with only very few exceptions) been realised by incorporation of strongly polar terminal groups especially such as a cyano (-CN) group or also a isothiocyanato (-NCS) group as e.g. in EP 01 101 157. Use of compounds of these types, however, leads to mesogenic media, especially for use in TN type displays, with rather low specific resistivity, which in turn do not match the demanding requirements for the voltage holding ratio of the media in displays driven by an active matrix, as e.g. The respective functional or modulation media used for the displays are disclosed in DE 102 17 273 A1.
In contrast, mesogenic media consisting predominantly or even entirely of mesogenic compounds with a terminal fluorine substitution or with a fluorinated terminal group, so far, do not provide a dielectric anisotropy, which is high enough to realise low operation voltages, especially if they are used in light modulation media for the displays disclosed in DE 102 17273 which are most demanding in this respect.
Mesogenic compounds with two lateral alkoxy groups like e.g.
Figure imgf000006_0001
have been hinted at in U.S. 6,177,154. The compounds realised so far, however, do not show the extremely high values for the dielectric anisotropy and/or the optical anisotropy required here. These compounds further are not particularly reliable and neither are readily available (i.e. rather difficult to prepare), nor particularly well soluble. Thus, there is a significant need for liquid crystal media with suitable properties for practical applications such as a very high dielectric anisotropy, a suitably wide nematic phase range or at least sufficient mesogenity for use in practical media, low viscosities, appropriate optical anisotropy Δn according to the display mode used, which also are readily accessible.
Further the media used so far for the displays disclosed in DE 102 17273 A1 and in DE 103 13 979.6 all tend to lead to rather pronounced temperature dependence of the characteristic voltages.
Present invention
Surprisingly, it now has been found that mesogenic media with high Δε especially useful for displays disclosed in DE 102 17273 A1 and in particular in DE 103 13 979.6 can be realised, which do not exhibit the drawbacks of the materials of the prior art, or at least do exhibit them to a significantly lesser degree.
Last not least, the compounds of the instant invention are particularly well suited for use in light modulation elements and displays using a modulation medium which is in an optically isotropic state, preferably in the blue phase, as disclosed in DE 103 13979.6. In these displays the inventive compounds do lead to a significant decrease of the temperature dependence of the characteristic voltages and hence of the operation voltages and/or to a significant increase of the temperature range over which the temperature dependence is rather small.
These improved liquid crystal media according to the instant application are realized by using at least two components: a first liquid crystal component (called component A) comprising compounds of formula I, which are strongly dielectrically positive compounds with very high values of Δε and also Δn
Figure imgf000007_0001
wherein a, b, c and d are independently of each other 0, 1 or 2, whereby a + b + c + d < 4;
R11 is hydrogen, an alkyl or alkoxy radical having from 1 to 15 carbon atoms, wherein one or more methylene groups of said alkyl or alkoxy radical may be replaced independently of each other by -O-, -S-, -SiRxRy-, -CH=CH-, -C≡C-, -CO-O- and/or -O-CO- such that oxygen and/or sulfur atoms are not linked directly to each other, said alkyl or alkoxy radical being unsubstituted or mono- substituted with a -CN group or mono- or poly- substituted with halogen; or aryl, aryloxy, alkylaryl, alkylaryloxy, alkylarylalkyl, alkylarylalkoxy, cycloalkyl, cycloalkyloxy, cycloalkylalkenyloxy, alkylcycloalkyl, alkylcycloalkyloxy or aikylcycloalkylalkenyloxy, each with up to 15 carbon atoms, wherin said in radicals being unsubstituted or mono-substituted with a -CN group or mono- or poly-substituted with halogen one ore more =CH- groups may be replaced independently of each other by =N- and/or one more -CH2- groups may be replaced independently of each other by -O-, -S-, -SiRxRy-, ~CH=CH-, -C≡C-, -CO-O- and/or -O-CO- such that nitrogen and oxygen and/or sulfur atoms are not linked directly to each other; L11, L12, L13 and L14 are, independently of each other, hydrogen, an alkyl or alkoxy radical having from 1 to 15 carbon atoms, wherein one or more methylene groups of said alkyl or alkoxy radical may be replaced independently of each other by -0-, -S-, -SiRxRy-, - CH=CH-, -C≡C-, -CO-O- and/or -O-CO- such that oxygen and/or sulfur atoms are not linked directly to each other, said alkyl or alkoxy radical being unsubstituted or mono-substituted with a -CN group or mono- or poly-substituted with halogen; or aryl, aryloxy, alkylaryl, alkylaryloxy, alkylarylalkyl, alkylarylalkoxy, cycloalkyl, cycloalkyloxy, cycloalkylalkenyloxy, alkylcycloalkyl, alkylcycloalkyloxy or alkylcycloalkylalkenyloxy, each with up to 15 carbon atoms, wherin said in radicals being unsubstituted or mono-substituted with a -CN group or mono- or poly-substituted with halogen one ore more =CH- groups may be replaced independently of each other by =N- and/or one more -CH2- groups may be replaced independently of each other by -0-, -S-, -SiRxRy-, -CH=CH-, -C≡C-, -CO-O- and/or -O-CO- such that nitrogen and oxygen and/or sulfur atoms are not linked directly to each other, whereby preferably L13 and L14 are hydrogen, if at least one of L11 and L12 is not hydrogen; L and L12 are hydrogen, if at least one of L13 and L14 is not hydrogen; at least one of L11, L12, L13 and L14 is not hydrogen; and L11 and L12 are not halogen at the same time;
X11 is H, halogen, -CN, -NCS, -SF5> -S-Rz, -SO2-Rz, an alkyl or alkoxy radical having from 1 to 15 carbon atoms, wherein one or more methylene groups of said alkyl or alkoxy radical may be replaced independently of each other by -0-, -S-, -SiRxRy-, -CH=CH-, -C≡C-, -CO-O- and/or -O-CO- such that oxygen and/or sulfur atoms are not linked directly to each other, said alkyl or alkoxy radical being unsubstituted or mono-substituted with a -CN group or mono- or poly-substituted with halogen; or aryl, aryloxy, alkylaryl, alkylaryloxy, alkylarylalkyl, alkylarylalkoxy, cycloalkyl, cycloalkyloxy, cycloalkylalkenyloxy, alkylcycloalkyl, alkylcycloalkyloxy or alkylcycloalkylalkenyloxy, each with up to 15 carbon atoms, wherin said in radicals being unsubstituted or mono-substituted with a -CN group or mono- or poly-substituted with halogen one ore more =CH- groups may be replaced independently of each other by =N- and/or one more -CH2- groups may be replaced independently of each other by -0-, -S-, -SiRxRy-, - CH=CH-, -C≡C-, -CO-O- and/or -O-CO- such that nitrogen and oxygen and/or sulfur atoms are not linked directly to each other; Rx and Ry are independently of each other hydrogen or an alkyl radical having from 1 to 7 carbon atoms; Rz is an alkyl radical having from 1 to 7 carbon atoms, said alkyl radical being unsubstituted or mono- or poly-substituted with halogen; A11, A12, A13 and A14 are independently of each other a ring of one of the following formulas:
Figure imgf000010_0001
A11, A12, A13 and A14 may be the same ring or two
35 different rings if present more than once; Y11, Y12, Y13 and Y 4 are independently of each other hydrogen, halogen, an alkyl or alkoxy radical having from 1 to 15 carbon atoms wherein one or more methylene groups of said alkyl or alkoxy radical may be replaced independently of each other by -0-, -S-, -SiRxRy-, -CH=CH-, -C≡C-, -CO-O- and/or -O-CO- such that oxygen and/or sulfur atoms are not linked directly to each other, said alkyl or alkoxy radical being unsubstituted or mono- or poly- substituted with halogen; or aryl, aryloxy, alkylaryl, alkylaryloxy, alkylarylalkyl, alkylarylalkoxy, cycloalkyl, cycloalkyloxy, cycloalkylalkenyloxy, alkylcycloalkyl, alkylcycloalkyloxy or alkylcycloalkylalkenyloxy, each with up to 15 carbon atoms, wherin said in radicals being unsubstituted or mono-substituted with a -CN group or mono- or poly-substituted with halogen one ore more =CH- groups may be replaced independently of each other by =N- and/or one more -CH2- groups may be replaced independently of each other by -0-, -S-, -SiRxRy-, - CH=CH-, -C≡C-, -CO-O- and/or -O-CO- such that nitrogen and oxygen and/or sulfur atoms are not linked directly to each other; f, g, h and j are independently of each other 0, 1 , 2 or 3;
Z11, Z12, Z13 and Z14 are independently of each other a single bond, -CH2CH2-,(-CH2CH2-)2, -CF2-CF2-, -CF2 _CH -,
Figure imgf000011_0001
-CH=CF-, -C≡C-, -CH2O-, -OCH2-, -CF20-, -OCF2-, -CO-O- or -O-CO- whereby each of Z11 , Z12, Z13 and Z14 may have the same or a different meaning if present more than once,
and preferably of its sub-formula 1-1
Figure imgf000012_0001
Wherein the parameters are as defined above and preferably
R11, R12 and R13 , independently of each other, are n-alkyl or n-alkoxy with 1 to 20, preferably 1 to 10, preferably 1 to 8, preferably 2 to 8, preferably 2 to 6 C-atoms, alkenyl, alkenyloxy or alkoxyalkyl with 2 to 20, preferably 2 to 8, preferably 2 to 6, preferably 2 to 5 C-atoms or CN, NCS, halogen, preferably F, Cl, halogenated alkyl, alkenyl or alkoxy, preferably mono-, di- or oligo-fluorinated alkyl, alkenyl or alkoxy, especially preferred CF3 OCF2H or OCF3, preferably R11, R12 and R13 are alkoxy, preferably with 1 to 10 C-atoms,
L11, L12, Y11 and Y12 , independently of each other, are H, halogen, preferably F or Cl, CN, NCS, unsubstituted or halogenated alkyl, alkenyl, alkoxy, aryl, aryloxy, alkylaryl, alkylaryloxy, alkylarylalkyl, alkylarylalkoxy, cycloalkyl, cycloalkyloxy, cycloalkylalkenyloxy, alkylcycloalkyl, alkylcycloalkyloxy or alkylcycloalkylalkenyloxy, each with up to 15 carbon atoms, wherin said in radicals being unsubstituted or mono-substituted with a -CN group or mono- or poly-substituted with halogen one ore more =CH- groups may be replaced independently of each other by =N- and/or one more -CH2- groups may be replaced independently of each other by -0-, -S-, -SiRxRy-, - CH=CH-, -C≡C-, -CO-O- and/or -O-CO- such that nitrogen and oxygen and/or sulfur atoms are not linked directly to each other, preferably mono-, di- or oligo-fluorinated alkyl, alkenyl or alkoxy, especially preferred CF3) OCF2H or OCF3, preferably F or Cl, halogenated alkyl, alkenyl or alkoxy, preferably mono-, di- or oligo-fluorinated alkyl, alkenyl or alkoxy, especially preferred CF3, OCF2H or OCF3) preferably at least one of L11 and R12 is, most preferably both are F and Y11 and Y12, independently of each other, preferably H or F and X11 is H, halogen, preferably F or Cl, CN, NCS, SF5, -SCF3, -S02CF3, -S02C2F5, -SO2C4F9, unsubstituted or halogenated alkyl, alkenyl, alkoxy, aryl, aryloxy, alkylaryl, alkylaryloxy, alkylarylalkyl, alkylarylalkoxy, cycloalkyl, cycloalkyloxy, cycloalkylalkenyloxy, alkylcycloalkyl, alkylcycloalkyloxy or alkylcycloalkylalkenyloxy, each with up to 15 carbon atoms, wherin said in radicals being unsubstituted or mono-substituted with a -CN group or mono- or poly-substituted with halogen one ore more =CH- groups may be replaced independently of each other by =N- and/or one more -CH2- groups may be replaced independently of each other by -0-, -S-, -SiRxRy-, -CH=CH-, -C≡C-, -CO-O- and/or -O-CO- such that nitrogen and oxygen and/or sulfur atoms are not linked directly to each other, preferably mono-, di- or oligo-fluorinated alkyl, alkenyl or alkoxy, preferably F or Cl, CN, unsubstituted or halogenated alkyl, alkenyl or alkoxy, preferably mono-, di- or oligo-fluorinated alkyl, alkenyl or alkoxy, especially preferred F, CF3 or OCF3.
In a preferred embodiment of the present invention one or more of the groups R11, L11, L12, L13, L14, Y11, Y12, Y13, Y14 and X11, which are present in the compounds of formula I, is/are a chiral group, which preferably is a group of formula I* -Q1-CH-Q2 I Q3 ,*
wherein
Q1 is an alkylene or alkylene-oxy group with 1 to 9 C atoms or a single bond,
Q2 is an alkyl or alkoxy group with 1 to 10 C atoms which may be unsubstituted, mono- or polysubstituted by F, Cl, Br or CN, it being also possible for one or more non-adjacent CH2 groups to be replaced, in each case independently from one another, by -C≡C-, -0-, -S-, -NH-, -N(CH3)-, -CO-, -COO-, -OCO-, -OCO-0-, -S-CO- or -CO-S- in such a manner that oxygen atoms are not linked directly to one another,
Q3 is F, Cl, Br, CN or an alkyl or alkoxy group as defined for Q2 but being different from Q2.
In case Q1 in formula I* is an alkylene-oxy group, the O atom is preferably adjacent to the chiral C atom.
Preferred chiral groups of formula I* are 2-alkyl, 2-alkoxy, 2-methylalkyl, 2- methylalkoxy, 2-fluoroalkyl, 2-fluoroalkoxy, 2-(2-ethin)-alkyl, 2-(2-ethin)-alkoxy, 1 ,1 ,1 -trif luoro-2-alkyl and 1 ,1 ,1 -trif luoro-2-alkoxy.
Particularly preferred chiral groups I* are 2-butyl (=1-methylpropyl), 2- methylbutyl, 2-methylpentyl, 3-methylpentyl, 2-ethylhexyl, 2-propylpentyl, in particular 2-methylbutyl, 2-methylbutoxy, 2-methylpentoxy, 3- methylpentoxy, 2-ethylhexoxy, 1-methylhexoxy, 2-octyloxy, 2-oxa-3- methylbutyl, 3-oxa-4-methylpentyl, 4-methylhexyl, 2-hexyl, 2-octyl, 2-nonyl, 2-decyl, 2-dodecyl, 6-methoxyoctoxy, 6-methyloctoxy, 6- methyloctanoyloxy, 5-methylheptyloxycarbonyl, 2-methylbutyryloxy, 3- methylvaleroyloxy, 4-methylhexanoyloxy, 2-chlorpropionyloxy, 2-chloro-3- methylbutyryloxy, 2-chloro-4-methylvaleryloxy, 2-chloro-3-methylvaleryloxy, 2-methyl-3-oxapentyl, 2-methyl-3-oxahexyl, 1 -methoxypropyl-2-oxy, 1- ethoxypropyl-2-oxy, 1 -propoxypropyl-2-oxy, 1-butoxypropyl-2-oxy, 2- fluorooctyloxy, 2-fluorodecyloxy, 1 ,1,1 -trif luoro-2-octyloxy, 1 ,1 ,1 -trif luoro-2- octyl, 2-fluoromethyIoctyIoxy for example. Very preferred are 2-hexyl, 2- octyl, 2-octyloxy, 1 ,1,1 -trif luoro-2-hexyl, 1,1 ,1 -trif luoro-2-octyl and 1 ,1 ,1- trifiuoro-2-octyloxy.
In addition, compounds containing an achiral branched alkyl group may occasionally be of importance, for example, due to a reduction in the tendency towards crystallization. Branched groups of this type generally do not contain more than one chain branch. Preferred achiral branched groups are isopropyl, isobutyl (= methylpropyl), isopentyl (= 3-methylbutyl), isopropoxy, 2-methyl-propoxy and 3-methylbutoxy.
In a further preferred embodiment, which may be different or identical to the previously described embodiments, at least one and preferably one of the rings A11, A12, A13 and A14, which are present in the compound of formula 1 is a chiral moiety, preferably selected from the group of cholesterine-diyl, pinimenthol-diyl and tetrahydropyrane-diyl and most preferably tetrahydropyrane-diyl.
In a further preferred embodiment of the present invention, which may be different or identical to the previously described embodiments, one or more of the groups R11, L11, L12, L13, L14, Y11, Y12, Y13, Y14 and X11, which are - present in the compounds of formula I, is/are PG-SG wherein SG is a spacer group and
PG is a polymerisable or reactive group.
The polymerisable or reactive group PG is preferably selected from
Figure imgf000015_0001
CH2=CW2-(0)k , CH3-CH=CH-0-, (CH2=CH)2CH-OCO-, (CH2=CH-CH2)2CH-OCO-, (CH2=CH)2CH-0-, (CH2=CH-CH2)2N-, HO-CW2W3-, HS-CW2W3-, HW N-, HO-CW2W3-NH-,
CH2=CW1-CO-NH-, CH2=CH-(COO)k1-Phe-(0)κ2-, Phe-CH=CH-, HOOC-, OCN-, and W4W5W6Si-, with W being H, Cl, CN, phenyl or alkyl with 1 to 5 C-atoms, in particular H, Cl or CH3, W2 and W3 being independently of each other H or alkyl with 1 to 5 C-atoms, in particular methyl, ethyl or n- propyl, W4, W5 and W6 being independently of each other Cl, oxaalkyl or oxacarbonylalkyl with 1 to 5 C-atoms, Phe being 1 ,4-phenylene and ki and k2 being independently of each other 0 or 1.
Especially preferably PG is a vinyl group, an acrylate group, a methacrylate group, an oxetane group or an epoxy group, especially preferably an acrylate or methacrylate group.
As for the spacer group SG all groups can be used that are known for this purpose to those skilled in the art. The spacer group SG is preferably of formula SG'-X, such that PG-SG- is PG-SG'-X-, wherein
SG' is alkylene with up to 20 C atoms which may be unsubstituted, mono- or poly-substituted by F, Cl, Br, I or CN, it being also possible for one or more non-adjacent CH2 groups to be replaced, in each case independently from one another, by -0-, -S-, -NH-, -NR01-, -SiR01R02-, -CO-, -COO-, -OCO-, -OCO-0-, -S-, -CO-, -CO-S-, -CH=CH- or -C≡C- in such a manner that O and/or S atoms are not linked directly to one another,
X is -0-, -S-, -CO-, -COO-, -OCO-, -0-COO-, -CO-NR01-, -NR01-CO-, - OCH2-, -CH20-, -SCH2-, -CH2S-, -CF20-, -OCF2-, -CF2S-, -SCF2-, -CF2CH2-, -CH2CF2-, -CF2CF2-, -CH=N-, -N=CH-, -N=N-, -CH=CR01-, -CY01=CY02-, -C≡C-, -CH=CH-COO-, -OCO-, -CH=CH- or a single bond, and
R01, R02, Y01 and Y02 have one of the respective meanings given above.
X is preferably -0-, -S-, -OCH2-, -CH20-, -SCH2-, -CH2S-, -CF20-, -OCF2-, -CF2S-, -SCF2-r -CH2CH2-, -CF2CH2-, -CH2CF2-, -CF2CF2-, -CH=N-, -N=CH-, -N=N-, -CH=CR0-, -CY02=CY02-, -C≡C- or a single bond, in particular -0-, -S-, -C≡C-, -CY01=CY02- or a single bond, very preferably a group that is able to from a conjugated system, such as -C≡C- or -CY°1=CY02-, or a single bond.
Typical groups SG' are, for example, -(CH2)P-, -(CH2CH20)q -CH2CH2-, -CH2CH2-S-CH2CH2- or -CH2CH2-NH-CH2CH2- or -(SiR°R00-O)p-, with p being an integer from 2 to 12, q being an integer from 1 to 3 and R°, R00 and the other parameters having the meanings given above.
Preferred groups SG' are ethylene, propylene, butylene, pentylene, hexylene, heptylene, octylene, nonylene, decylene, undecylene, dodecylene, octadecylene, ethyleneoxyethylene, methyleneoxybutylene, ethylene-thioethylene, ethylene-N-methyl-iminoethylene, 1 -methylalkylene, ethenylene, propenylene and butenylene for example.
In another preferred embodiment SG' is a chiral group of formula I*': * 4
-Q1-CH-Q'
Q3
wherein
Q1 and Q3 have the meanings given in formula I*, and
Q4 is an alkylene or alkylene-oxy group with 1 to 10 C atoms or a single bond, being different from Q1,
with Q1 being linked to the polymerisable group PG.
Further preferred are compounds with one or two groups PG-SG- wherein SG is a single bond.
In case of compounds with two groups PG-SG, each of the two polymerisable groups PG and the two spacer groups SG can be identical or different. ln a preferred embodiment of the instant are compounds of formula I wherein at one or more, preferably two, three or more, of the radicals
R1\ L11, L12, L13, L14,Y1\ Y12, Y13, Y14 and X11, which are resent, is/are aryl, aryloxy, alkylaryl, alkylaryloxy, alkylarylalkyl, alkylarylalkoxy, cycloalkyl, cycloalkyloxy, cycloalkylalkenyloxy, alkylcycloalkyl, alkylcycloalkyloxy or alkylcycloalkylalkenyloxy, preferably aryloxy, alkylaryloxy, cycloalkyloxy, cycloalkylalkenyloxy, alkylcycloalkyloxy or alkylcycloalkylalkenyloxy, each with up to 15 carbon atoms, wherin said in radicals being unsubstituted or mono- substituted with a -CN group or mono- or poly-substituted with halogen one ore more =CH- groups may be replaced independently of each other by =N- and/or one more -CH2- groups may be replaced independently of each other by -0-, -S-, -SiRxRy-, -CH=CH-, -C≡C-, -CO-O- and/or -O-CO- such that nitrogen and oxygen and/or sulfur atoms are not linked directly to each other.
Preferably one or more, preferably two, three or more, of the radicals
R11, L11, L12, L13, L1 ,Y11, Y 2, Y13, Y14 and X11, which are present,
Figure imgf000018_0001
Figure imgf000019_0001
and wherein
Rx has the meaning given above and preferably is n-alkyl and most preferably methyl.
Preferably the mesogenic media according to the present invention simultaneously comprise a second mesogenic, liquid crystalline component (called component B), which is a dielectrically positive component comprising, and preferably consisting of terminally polar substituted bi- or terphenyl compounds, which or some of which optionally are laterally fluorinated, preferably of formula II
Figure imgf000020_0001
wherein
n2 is O, 1 , 2 or 3,
R^ has the meaning given for R11 under formula I, preferably under formula 1-1 above, but preferably is alkyl or alkenyl,
Z21 and Z22 , independently of each other, are a single bond, -CH2CH2-,(-CH2CH2-)2, -CF2-CF -, -CF2-CH2-, -CH2-CF2- , -CH=CH-, -CF=CF-, -CF=CH-, -CH=CF-, -C≡C-, -CH2O-, -OCH2-, -CF2O-, -OCF2-, -CO-O- or -O-CO- (whereby each of Z22 may have the same or a different meaning if present more than once), preferably a single bond, -C≡C-, -CF2O- or -CO-O-, especially a single bond,
Figure imgf000020_0002
each, independently of each other, are
Figure imgf000020_0003
Figure imgf000021_0001
whereby also may be
and
X2 is CN, SF5, SO2CF3, NCS, CF3, OCF3> F or Cl, preferably CN, NCS or Cl, most preferably CN or NCS.
Preferably the mesogenic media according to the instant invention contain a component A comprising, preferably predominantly consisting of and most preferably entirely consisting of compounds of formula I.
The compounds of formula I, wherein at least one of L11 and L12 is F and / or wherein at least one of Y11 and Y12 is F are preferred
Liquid crystal compounds in this application embrace compounds with a liquid crystalline phase by themselves as well as compounds, which are compatible with mesogenic phases, especially with the nematic phase, without decreasing the clearing point unacceptably. The latter compounds have a mesogenic structure and are also called mesogenic compounds.
The compounds of formula I can be prepared according to the following reaction schemes, Scheme 1 to 4, or variants thereof which will be easily recognized by the person skilled in the art. Scheme 1
Suzuki coupling with
Figure imgf000022_0002
wherein
R, R' and R" , independently from each other, are alkyl, alkoxy, alkenyl, alkenyloxy or oxaalkyl, preferably alkoxy, preferably R' and R" and most preferably R, R' and R" are identical to each other, and Y11 and Y12 , independently of each other, are as defined hereinbefore. Scheme 2
1.Et2NSiMe3,
Figure imgf000023_0001
1.n-BuLi,THF,
Figure imgf000023_0002
Suzuki coupling with
Figure imgf000023_0003
Figure imgf000023_0004
Figure imgf000023_0005
wherein R and X-11 is as defined above and R'" is other, alkyl, alkenyl, alkenyloxy, oxaalkenyl or oxaalkyl. It should be noted that -OR"' radicals having different meanings for R'" can easily be introduced by stepwise
reaction of
Figure imgf000024_0001
with (1) 1 equivalent of an alcohol R"'a-OH in the presence of NaH at a reaction temperature of about 80 °C and (2) 1 equivalent of an alcohol R",b-OH in the presence of NaH at a reaction temperature of about 120 °C.
Scheme 3
Figure imgf000024_0002
wherein R ,11 , 1 L 11 and L 12 are as defined hereinbefore and X is H or F. Scheme 4
Figure imgf000025_0001
wherein R11, L11, L12 have the same meaning as given above for general formula I.
Comprising in this application means in the context of compositions that the entity referred to, e.g. the medium or the component, contains the compound or compounds in question, preferably in a total concentration of 10 % or more and most preferably of 20 % or more.
Predominantly consisting, in this context, means that the entity referred to contains 80 % or more, preferably 90 % or more and most preferably 95 % or more of the compound or compounds in question.
Entirely consisting, in this context, means that the entity referred to contains 98 % or more, preferably 99 % or more and most preferably 100.0 % of the compound or compounds in question.
The compounds of formula I are preferably selected from the group of sub- formulae 1-1.1 to 1-1.15, especially 1-1.1 , 1-1.2, 1-1.3, 1-1.4 and/or 1-1.5:
Figure imgf000026_0001
Figure imgf000027_0001
Figure imgf000028_0001
wherein the parameters have the respective meanings given under formula I above and preferably
R11 to R13 are identical to each other and preferably are alkoxy, alkenyloxy, halogenated alkoxy or oxaalkoxy, and
Y11 and Y12 are independently of each other H, CF3 or F.
The compounds of formulae 1-1.1 to 1-1.5 preferably are selected from the group of compounds of formula 1-1 A
Figure imgf000028_0002
wherein
R, R', R" X, Y11 and Y12 are as defined above, preferably
X is F, CF3, SF5, SO2CF3, OCF3 or CN and
Y11 and Y12 are independently of each other H, CF3 or F.
Likewise compounds of formula 1-1 A having only one or no F substituent at the middle phenyl ring are preferred as well.
In a preferred embodiment the liquid crystalline media according to the instant invention contains a component B comprising, preferably predominantly consisting of compounds of formula II as defined hereinbefore.
Preferably in these compounds of formula II
R2 is alkyl or alkoxy, wherein one or more methylene groups of said alkyl may be replaced -C≡C-, and for sub-formulae lib and lie preferably alkyl.
Additionally the media according to the present invention may contain a component C. This component C may be dielectrically neutral or dielectrically negative, depending upon the relative amounts of compounds with positive and negative dielectrical anisotropy contained therein.
Component C is used in a concentration of 0 to 40 %, preferably 0 to 20 % and most preferably from 0 to 10 % of the total mixture.
Optionally the inventive liquid crystal medium contains a further component D, which is a dielectrically neutral component and preferably comprises and more preferably consists of dielectrically neutral compounds.
Component D is used to adjust especially the phase range and the optical anisotropy of the inventive liquid crystal media.
The concentration of component D in the liquid crystal medium according to the present invention is preferably 0 % to 40 %, more preferably 0 % to 25 %, most preferably 0 % to 15 % and in particular 3 to 10 %.
Optionally the inventive liquid crystal medium contains a further component E, which is a chiral component and preferably comprises and more preferably consists of chiral compounds. It is preferred that the liquid crystal medium according to the invention contains that further chiral component E.
Optionally, the inventive media can comprise further liquid crystal compounds in order to adjust the physical properties. Such compounds are known to the expert. Their concentration in the media according to the instant invention is preferably 0 to 30 %, more preferably 0 to 20 % and most preferably 5 to15 %.
Preferably the liquid crystal medium contains 50 % to 100 %, more preferably 70 % to 100 % and most preferably 80 % to 100 % and in particular 90 % to 100 % totally of components A and B which contain, preferably predominantly consist of and most preferably entirely consist of one or more of compounds of formulae I and II, respectively.
In the present application the term dielectrically positive compounds describes compounds with Δε > 1 ,5, dielectrically neutral compounds are compounds with -1 ,5 < Δε < 1 ,5 and dielectrically negative compounds are compounds with Δε < -1 ,5. The same holds for components. Δε is determined at 1 kHz and 20 °C. The dielectrical anisotropies of the compounds is determined from the results of a solution of 10 % of the individual compounds in a nematic host mixture. The capacities of these test mixtures are determined both in a cell with homeotropic and with homogeneous alignment. The cell gap of both types of cells is approximately 10 μm. The voltage applied is a rectangular wave with a frequency of 1 kHz and a root mean square value typically of 0.1 V or 0.5 V to 1.0 V, however, it is always selected to be below the capacitive threshold of the respective test mixture.
For dielectrically positive compounds the mixture ZLI-4792 and for dielectrically neutral, as well as for dielectrically negative compounds, the mixture ZLI-3086, both of Merck KGaA, Germany are used as host mixture, respectively. The dielectric permittivities of the compounds are determined from the change of the respective values of the host mixture upon addition of the compounds of interest and are extrapolated to a concentration of the compounds of interest of 100 %.
Components having a nematic phase at the measurement temperature of 20 °C are measured as such, all others are treated like compounds. The term threshold voltage refers in the instant application to the optical threshold and is given for 10 % relative contrast (V-to) and the term saturation voltage refers to the optical saturation and is given for 90 % relative contrast (Vgo) both, if not explicitly stated otherwise. The capacitive threshold voltage (V0, also called Freedericks-threshold VFr) is only used if explicitly mentioned.
The ranges of parameters given in this application are all including the limiting values, unless explicitly stated otherwise.
Throughout this application, unless explicitly stated otherwise, all concentrations are given in mass percent and relate to the respective complete mixture, all temperatures are given in degrees centigrade (Celsius) and all differences of temperatures in degrees centigrade. All physical properties have been and are determined according to "Merck Liquid Crystals, Physical Properties of Liquid Crystals", Status Nov. 1997, Merck KGaA, Germany and are given for a temperature of 20 °C, unless explicitly stated otherwise. The optical anisotropy (Δn) is determined at a wavelength of 589.3 nm. The dielectric anisotropy (Δε) is determined at a frequency of 1 kHz. The threshold voltages, as well as all other electro- optical properties have been determined with test cells prepared at Merck KGaA, Germany. The test ceils for the determination of Δε had a cell gap of 22 μm. The electrode was a circular ITO electrode with an area of 1.13 cm2 and a guard ring. The orientation layers were lecithin for homeotropic orientation (ε| | ) and polyimide AL-1054 from Japan Synthetic Rubber for homogeneuous orientation (εj_). The capacities were determined with a frequency response analyser Solatron 1260 using a sine wave with a voltage of 0.3 Vrms. The light used in the electro-optical measurements was white light. The set up used was a commercially available equipment of Otsuka, Japan. The characteristic voltages have been determined under perpendicular observation. The threshold (\ o) - mid grey (V5o) - and saturation (V90) voltages have been determined for 10 %, 50 % and 90 % relative contrast, respectively.
The liquid crystal media according to the present invention may contain further additives and chiral dopants. It is especially preferred that they contain chiral dopants. The total concentration of these further constituents is in the range of 0 % to 20 %, preferably 0.1 % to 15 %, more preferably 1 to 15 %, especially 1 to 6 %, based in the total mixture. The concentrations of the individual compounds used each are preferably in the range of 0.1 to 3 %. The concentration of these and of similar additives is not taken into consideration for the values and ranges of the concentrations of the liquid crystal components and compounds of the liquid crystal media in this application.
The inventive liquid crystal media according to the present invention consist of several compounds, preferably of 3 to 30, more preferably of 5 to 20 and most preferably of 6 to 14 compounds. These compounds are mixed in conventional way. As a rule, the required amount of the compound used in the smaller amount is dissolved in the compound used in the greater amount. In case the temperature is above the clearing point of the compound used in the higher concentration, it is particularly easy to observe completion of the process of dissolution. It is, however, also possible to prepare the media by other conventional ways, e. g. using so called pre-mixtures, which can be e. g. homologous or eutectic mixtures of compounds or using so called multi-bottle-systems, the constituents of which are ready to use mixtures themselves.
By addition of suitable additives, the liquid crystal media according to the instant invention can be modified in such a way, that they are usable in all known types of liquid crystal displays, either using the liquid crystal media as such, like TN-, TN-AMD, ECB-, VAN-AMD and in particular in composite systems, like PDLC-, NCAP- and PN-LCDs and especially in HPDLCs. The LC media of the present invention are especially suitable for use in light modulation elements and displays using a modulation (or controlling) medium which is in an optically isotropic state, preferably in the blue phase.
The melting point T(C,N) or T(C;I), the transition from the smectic (S) to the nematic (N) phase T(S,N) and the clearing poin T(N,l) of the liquid crystals are given in degrees centigrade. ln the present application and especially in the following examples, the structures of the liquid crystal compounds are represented by abbreviations also called acronyms. The transformation of the abbreviations into the corresponding structures is straight forward according to the following two tables A and B. All groups CnH2n+ι and
CmH2m+ι are straight chain alkyl groups with n respectively m C-atoms. The interpretation of table B is self-evident. Table A only lists the abbreviations for the cores of the structures. The individual compounds are denoted by the abbreviation of the core followed by a hyphen and a code specifying the substituents Ri, R2, L^and L≥ follows:
Figure imgf000034_0001
nm CnH2n+1 CmH2m+l H H nOm CnH2n+1 'CmH2m+ι H H nO.m OCnH2n+1 mH2m+1 H H
Figure imgf000034_0002
nF.F CnH2n+ι F H F nF.F.F CnH2n+ι F F F
Figure imgf000034_0003
nCI CnH2n+1 Cl H H nCI.F CnH2n+i Cl H F nCI.F.F CnH2n+ι Cl F F nCF3 CnH2n+ι CF3 H H
Figure imgf000034_0004
nOCF3.F.F CnH2n+ι OCF3 F F nOCF2 CnH2n+ι OCHF2 H H nOCF2.F CnH2n+ι OCHF2 H F nOCF2.F.F CnH2n+ι OCHF2 F F nS CnH2n+ι NCS H H nS.F CnH2n+ι NCS H F nS.F.F nH2n+t NCS F F rVsN CrH2r+i-CH=CH-C3H2s- CN H H rEsN CrH2r+i-O-C3H2s- CN H H nAm nH2n+l COOCmH2m+ι H H nF.CI CnH2n+ι Cl H F Table A:
BCH
Figure imgf000035_0002
CPTP EPCH
Figure imgf000035_0003
CEPTP
Figure imgf000035_0004
HP ME
Figure imgf000035_0005
PCH PDX
Figure imgf000036_0001
BECH PTP
Figure imgf000036_0002
EBCH ME
Figure imgf000036_0003
EHP CQP
Figure imgf000036_0004
PUQP CCQP
Figure imgf000036_0005
ET Table B:
Figure imgf000037_0001
CGP-n.FX CGP-n.FX
(X = F, CF3, OCHF2 or OCF3) (X = F, CF3, OCHF2 or OCF3)
Figure imgf000037_0002
CGU-n-X B-nO.FN (X = F, CF3, OCHF2 or OCF3)
Figure imgf000037_0003
Inm
Figure imgf000037_0004
CB15 C15
Figure imgf000037_0005
CBC-nm
Figure imgf000038_0001
CBC-nmF
Figure imgf000038_0002
ECBC-nm
Figure imgf000038_0003
CHE
Figure imgf000038_0004
CP-V-N CP-nV-N
Figure imgf000038_0005
CPP-nV2-m
Figure imgf000038_0006
CPP-V-m CH ^-O-©-©-0
CPP-nV-m
Figure imgf000039_0001
CPP-V2-m
Figure imgf000039_0002
G3n
Figure imgf000039_0003
K3n M3n
Figure imgf000039_0004
PG-n-AN
Figure imgf000039_0005
PU-n-AN
Figure imgf000039_0006
MU-n-AN
Figure imgf000040_0001
PPYRP-nN
Figure imgf000040_0002
PPYP-nN
Figure imgf000040_0003
PGP-n-N
Figure imgf000040_0004
PGIP-n-N
Figure imgf000040_0005
PVG-n-S
Figure imgf000040_0006
PVG-nO-S
Figure imgf000041_0001
PVG-V-S
Figure imgf000041_0002
PVG-nV-S
Figure imgf000041_0003
PVG-Vn-S
Figure imgf000041_0004
PPVU-n-S
Figure imgf000041_0005
CPVP-n-N
Figure imgf000041_0006
PTP-n(0)-S CnH2n+1-(O)- O C≡C- O -NCS
PTG-n(0)-S
Figure imgf000042_0001
PTU-n(0)-S
CnH2π+l" (O)- O -C≡C- O -CN
PTP-n(0)-N
Figure imgf000042_0002
PTG-n(0)-N
Figure imgf000042_0003
PTU-n(0)-N
CnH2n+1-(O)- O >-C≡C-< O V— ( O V- CN
PTPG-n(0)-N
Figure imgf000043_0001
GGP-n-CL
Figure imgf000043_0002
PGIGI-n-CL
Figure imgf000043_0003
CGU-n-F
CM "2n+1 ° > — ( o > — < O NCS
PPU-n-S
Figure imgf000043_0004
PGU-n-S
Figure imgf000044_0001
PPU-n-F
Figure imgf000044_0002
PGU-n-F
Figure imgf000044_0003
PPU-n-T
Figure imgf000044_0004
PGU-n-T
Figure imgf000044_0005
BB3n
Figure imgf000045_0001
PPTUI-n-m
Figure imgf000045_0002
GZU-nA-N
Figure imgf000045_0003
GZU-nO-N F
c n H 2n+r-c≡c_ < ° >— coo — ( o V-CN
UZU-nA-N
Figure imgf000045_0004
CUZU-n-F
Figure imgf000046_0001
CUZU-n-T
Figure imgf000046_0002
CUZU-n-N
Figure imgf000046_0003
PUZU-n-F
Figure imgf000046_0004
PUZU-n-T
Figure imgf000046_0005
PUZU-n-N
Figure imgf000047_0001
AUZU-n-F
Figure imgf000047_0002
AUZU-n-T
Figure imgf000047_0003
AUZU-n-N
Figure imgf000047_0004
AUUQP-n-F
Figure imgf000047_0005
AUUQP-n-T
Figure imgf000048_0001
AUUQP-n-OT
Figure imgf000048_0002
AUUQP-n-N
Figure imgf000048_0003
AUUQU-n-F
Figure imgf000048_0004
AUUQU-n-T
Figure imgf000048_0005
AUUQU-n-OT
Figure imgf000049_0001
AUUQU-n-N
Figure imgf000049_0002
AUUQGU-n-F
Figure imgf000049_0003
CUZP-n-SF5
Figure imgf000049_0004
PUZP-n-SF5
Figure imgf000049_0005
AUZP-n-SF5
Figure imgf000050_0001
AUUQP-n-SF5
Figure imgf000050_0002
P(Om)2PQP-nO-F
Figure imgf000050_0003
P(Om)2PQG-nO-F
Figure imgf000050_0004
P(Om)2PQU-nO-F
Figure imgf000050_0005
P(Om)2GQP-nO-F
Figure imgf000051_0001
P(Om)2GQG-nO-F
Figure imgf000051_0002
P(Om)2GQU-nO-F
Figure imgf000051_0003
P(Om)2UQP-nO-F
Figure imgf000051_0004
P(Om)2UQG-nO-F
Figure imgf000051_0005
P(Om)2UQU-nO-F
Figure imgf000052_0001
P(Om)2PQP-nO-T
Figure imgf000052_0002
P(Om)2PQG-nO-T
Figure imgf000052_0003
P(Om)2PQU-nO-T
Figure imgf000052_0004
P(Om)2GQP-nO-T
Figure imgf000052_0005
P(Om)2GQG-nO-T
Figure imgf000053_0001
P(Om)2GQU-nO-T
Figure imgf000053_0002
P(Om)2UQP-nO-T
Figure imgf000053_0003
P(Om)2UQG-nO-T
Figure imgf000053_0004
P(Om)2UQU-nO-T
Figure imgf000053_0005
P(Om)2PQP-nO-OT
Figure imgf000054_0001
P(Om)2PQG-nO-OT
Figure imgf000054_0002
P(Om)2PQU-nO-OT
Figure imgf000054_0003
P(Om)2GQP-nO-OT
Figure imgf000054_0004
P(Om)2GQG-nO-OT
Figure imgf000054_0005
P(Om)2GQU-nO-OT
Figure imgf000055_0001
P(Om)2UQP-nO-OT
Figure imgf000055_0002
P(Om)2UQG-nO-OT
Figure imgf000055_0003
P(Om)2UQU-nO-OT
Figure imgf000055_0004
P(Om)2PQPU-nO-SF5
Figure imgf000055_0005
P(Om)2PQU-nO-SF5
Figure imgf000056_0001
P(Om)2UQU-nO-SF5
Figure imgf000056_0002
P(Om)2UQU-nO-SF5
Figure imgf000056_0003
P(Om)2UQG(T)-nO-T
Figure imgf000056_0004
P(Om)2UQP(T)2-nO-T
Figure imgf000056_0005
P(On)2UQU-nO-OT
Figure imgf000057_0001
B(OC)2C*H-C-n
Figure imgf000057_0002
B(OC)2C*H-C-3 bzw. R-5011 / S-5011
Figure imgf000057_0003
BO2C*H-n BO2C*F-n
Figure imgf000057_0004
BO2C*H-C-n BO2C*F-C-n
Figure imgf000057_0005
BO2C*H-CC-n
Figure imgf000058_0001
BO2C*F-CC-n
Figure imgf000058_0002
(nOPZ)2X*
Figure imgf000058_0003
(nOPZPZ)2X*
Figure imgf000058_0004
SS-(nCPZ)2BE
Figure imgf000059_0001
RR-(nCPZ)2BE
Figure imgf000059_0002
C15
Figure imgf000059_0003
CB15
Figure imgf000059_0004
CM 21
Figure imgf000059_0005
R/S-811
Figure imgf000059_0006
CM 44
Figure imgf000060_0001
CM 45
Figure imgf000060_0002
CM 47
Figure imgf000060_0003
CN
Figure imgf000060_0004
RS-2011
Figure imgf000060_0005
RS-1011
Figure imgf000060_0006
RS-3011
Figure imgf000061_0001
R S-4011
Figure imgf000061_0002
R-5011 / S-5011
The liquid crystal media according to the instant invention do contain preferably four or more compounds selected from the group of compounds of tables A and B and/or five or more compounds selected from the group of compounds of table B and/or two or more compounds selected from the group of compounds of table A.
Examples
The examples given in the following are illustrating the present invention without limiting it in any way.
However, the physical data especially of the compounds illustrate to the expert which properties can be achieved in which ranges. Especially the combination of the various properties, which can be preferably achieved, is thus well defined. Example 1
1-[2,6-difIuoro-(4-(2,4,6-tri-/?-propoxyphenyl)phenyl)difluoromethoxy]-3,4,5- trifluorobenzene
Figure imgf000062_0001
is prepared according to Scheme I. It has a melting point of 70°C, a melting enthalpy of 6.8 kcal/mol and a glass transition temperature of -27°C. It is melting from the crystalline phase into the isotropic phase.
Example 2
Analogously to example 1 the corresponding compound with three n- butyloxy groups 1 -[2,6-difluoro-(4-(2,4,6-tri-r/-butoxyphenyl)phenyl)- difluoromethoxy]-3,4,5-trifluorobenzene
Figure imgf000062_0002
is prepared. It has a melting point of 51 °C, a melting enthalpy of
7.9 kcal/mol and, like the compound of example 1 , is melting from the crystalline phase to the isotropic phase.
Example 3
Analogously to example 1 the corresponding compound with three n- hexyloxy groups 1 -[2,6-difiuoro-(4-(2,4,6-tri-π-hexoxyphenyl)phenyl)- difluoromethoxy]-3,4,5-trifluorobenzene
Figure imgf000063_0001
is prepared. It has a melting point of -53°C and is melting from the glass phase to the isotropic phase.
Examples 4 to 45
Analogously to Example 1 the following compounds are prepared:
Figure imgf000063_0002
No. R11 to R13 γ11 Y12 Phases (T/°C) 4 CH3 H H
Figure imgf000063_0003
6 A7-C3H7 H H 7 π-C4H9 H H 8 π-CδHn H H
Figure imgf000063_0004
10 A7-C7H 5 H H
Figure imgf000063_0005
13 CH2=CH H H 14 CH2=CH-CH2 H H 15 E-CH3-CH2=CH H H 16 CH =CH-(CH2)2 H H
17 E-CH3-CH2 =CH~CH2 H H 18 H-CH3-CH -CH =CH H H 19 CH3 F H No. R11 to R13 γ11 γ12 Phases (T/°C)
Figure imgf000064_0001
26 -CsH 7 F H
Figure imgf000064_0002
28 CH2=CH F H 29 CH2 =CH-CH2 F H
Figure imgf000064_0003
32 E-CH3~CH2: =CH-CH2 F H
Figure imgf000064_0004
34 CH3 F F 35 C2H5 F F C 76°C l, Tg = -14°C 1 π-C3H7 F F C 70°C I, Tg = -53°C 2 n-C4H9 F F C 51°C I
Figure imgf000064_0005
40 CH2=CH F F
41 CH2 =CH-CH2 F F
Figure imgf000064_0006
43 CH2 =CH-(CH2)2 F F
44 E-CH3-CH2: =CH-CH2 F F 45 E-CH3-CH2-CH2 = =CH F F
Example 46
1-[2,6-difluoro-(4-(2,4,6-tri-r/-propoxyphenyl)phenyl)difluoromethoxy]-4- trifluoromethylbenzene
Figure imgf000065_0001
is prepared analogously to example 1. The compound has a melting point of 66°C and a melting enthalpy of 7.5 kcal/mol. It is melting from the crystalline glass phase into the isotropic phase.
Example 47
1-[2,6-difluoro-(4-(2,4,6-tri- 7-propoxyphenyl)phenyl)difluoromethoxy]-3,5- difluoro-4-trifluoromethylbenzene
Figure imgf000065_0002
is prepared analogously to example 1. The compound has a glass transition temperature of -23°C, a melting point of 50°C and a melting enthalpy of 6.8 kcal/mol. It is melting from the glass phase into the isotropic phase.
Examples 48 to 90
Analogously to Example 47 the following compounds are prepared:
Figure imgf000065_0003
R11 to R13 γ11 Y12 Phases (T/°C)
CH3 H H
Figure imgf000066_0001
A7-C3H7 H H C 66°C I
/1-C4H9 H H n-CδHn H H
Figure imgf000066_0002
n-C7H15 H H
/7-C8Hi7 H H
/7-CgH g H H
CH2=CH H H
CH2=CH-CH2 H H
E-CH3-CH2=CH H H
CH2 =CH-(CH2)2 H H
Figure imgf000066_0003
CH3 F H
Figure imgf000066_0004
n-C3H7 F H
Figure imgf000066_0005
n-CδHn F H
Figure imgf000066_0006
7-CgHig F H
Figure imgf000066_0007
E-CH3-CH2=CH F H
Figure imgf000066_0008
CH3 F F
Figure imgf000066_0009
π-C3H7 F F Tg = -23°C, C 50°C I r?-C4H9 F F No. R11 to R13 γ11 γ12 Phases (T/°C)
Figure imgf000067_0001
81 π-CβH 3 F F Tg = -50°C, C°C I
Figure imgf000067_0002
83 n-Cs π F F
Figure imgf000067_0003
85 CH2=CH F F 86 CH2=CH-CH2 F F 87 E-CH3-CH2=CH F F 88 CH2 =CH-(CH2)2 F F
Figure imgf000067_0004
90 E-CH3-CH2-CH2=CH F F
Examples 91 to 135
Analogously to Example 47 the following compounds are prepared:
Figure imgf000067_0005
No. R11 to R13 γ11 Y12 Phases (T/°C) 91 CH3 H H
Figure imgf000067_0006
94 n-C4H9 H H
Figure imgf000067_0007
99 /7-CgHig H. H 100 CH2=CH H H 101 CH2 =:CH-CH2 H H 102 E-CH3-CH2=CH H H No. R11 to R13 γ11 γ12 Phases (T/°C)
103 CH2 =CH-(CH2)2 H H
104 E-CH3-CH2 =CH-CH2 H H
105 E-CH3-CH -CH2= =CH H H
106 CH3 F H
Figure imgf000068_0001
108 A7-C3H7 F H
Figure imgf000068_0002
111 n-CθH ι3 F H
Figure imgf000068_0003
113 n-C ^ F H
Figure imgf000068_0004
115 CH2=CH F H
116 CH =CH-CH F H
117 E-CH3-CH2= =CH F H
118 CH =CH-(CH )2 F H
119 E-CH3-CH2 : =CH-CH2 F H
120 E-CH3-CH2- CH2= =CH F H
121 CH3 F F
122 C2Hδ F F
123 n-C3H7 F F
Figure imgf000068_0005
129 ri-CgHιg F F
130 CH2=CH F F
131 CH2 =CH-CH F F
132 E-CH3-CH2=CH F F
133 CH2 =CH-(CH2)2 F F
134 E-CH3-CH : =CH-CH2 F F
135 E-CH3-CH2-CH2 = =CH F F Example 136
Analogously to example 1
Figure imgf000069_0001
is prepared. The compound has a glass transition temperature of -31 °C. It is melting from the glass phase into the isotropic phase.
Example 137
Analogously to example 1 1-[2,6-difluoro-(4-(2,4,6-tri-/?-docecoxyphenyl)- phenyl)difluoromethoxy]-3,4,5-trifluorobenzene
Figure imgf000069_0002
is prepared. The compound has a melting point of 16°C, a melting enthalpy of 11.0 kcal/mol and an enthalpy of crystallisation of 3.7 kcal/mol. It is melting from the crystalline phase into the isotropic phase.
Example 138
Analogously to example 1 1-[2,6-difluoro-(4-(2,4,6-tri-π-propxyphenyl)- phenyl)difluoromethoxy]-3,5-difluoro-4-cyano-benzene
Figure imgf000070_0001
is prepared. The compound has a glass transition temperature of -14°C and a melting point of 89°C. It is melting from the glass phase into the isotropic phase.
Example 139 to 168
Analogously to Example 1 the following compounds are prepared:
Figure imgf000070_0002
No. R11 to R13 Y11 Phases (T/°C) 139 CH3 H 140 C2H5 H 141 π-C3H7 H 142 /7-C4H9 H 143 n-C5Hn H 144 n-C6H i3 H 145 π-C75 H
Figure imgf000070_0003
147 -C9Hi9 H 148 CH2=CH H 149 CH2=CH-CH2 H 150 E-CH3-CH2=CH H 151 CH2=CH-(CH2)2 H 152 E-CH3-CH2=CH-CH2 H 153 E-CH3-CH2-CH2=CH H 154 CH3 F No. R11 to R13 Y1 Phases (T/°C) 155 C2H5 F
Figure imgf000071_0001
160 A7-C7H15 F
Figure imgf000071_0002
162 n-CgHig F 163 CH2=CH F 164 CH =CH-CH2 F 165 E-CH3-CH2=CH F 166 CH2 =CH-(CH2)2 F 167 E-CH3-CH2 =CH-CH F 168 E-CH3~CH2-CH2 = =CH F
Example 169 to 258
Analogously to Example 1 the following compounds are prepared:
Figure imgf000071_0003
No. R 1"1 to R ,13 Y 11 Y 12 Phases (T/°C) 169 CH3 H H
Figure imgf000071_0004
171 n-C3H7 H H C 76°C
Figure imgf000071_0005
174 π-C6H i3 H H
Figure imgf000071_0006
177 n-CgHig H H 178 CH2=CH H H No. R11 to R13 γ11 γ12 Phases (T/°C) 179 CH2=CH-CH2 H H 180 E-CH3-CH2 =CH H H 181 CH2=CH-(CH2)2 H H 182 E-CH3-CH2 =CH-CH2 H H 183 E-CH3-CH2 -CH2=CH H H 184 CH3 F H 185 C2H5 F H
186 A7-C3H7 F H
Figure imgf000072_0001
188 A7-C5Hιι F H
189 /7-C6H i3 F H
Figure imgf000072_0002
193 CH2=CH F H
194 CH2=CH-CH2 F H
195 E-CH3-CH2= =CH F H
196 CH2=CH-(CH2)2 F H
197 E-CH3-CH2= =CH-CH2 F H
198 E-CH3-CH2- CH2=CH F H
199 CH3 CF3 H
200 C2H5 CF3 H
Figure imgf000072_0003
203 A7-C5H11 CF3 H
204 / -C6H i3 CF3 H
Figure imgf000072_0004
208 CH2=CH CF3 H
209 CH2=CH-CH2 CF3 H
210 E-CH3-CH2= =CH CF3 H
211 CH2=CH-(CH2)2 CF3 H
212 E-CH3-CH2=CH-CH2 CF3 H
213 E-CH3-CH2- CH2=CH CF3 H No. R11 to R13 Y11 Y12 Phases (T/°C) 214 CH3 F F
215 C2H5 F F
Figure imgf000073_0001
217 A7-C4H9 F F
218 π-C5Hn F F
219 /7-C6H 13 F F
Figure imgf000073_0002
222 n-CgHig F F
223 CH2=CH F F
224 CH2=CH-CH2 F F
225 E-CH3-CH2=CH F F
226 CH2=CH-(CH2)2 F F 227 E-CH3-CH2=CH-CH2 F F
228 E-CH3-CH2-CH2=CH F F
229 CH3 CF3 F
230 C2H5 CF3 F
Figure imgf000073_0003
232 A7-C4H9 CF3 F
Figure imgf000073_0004
234 n-C6H i3 CF3 F
235 π-C75 CF3 F
Figure imgf000073_0005
238 CH2=CH CF3 F
239 CH2=CH-CH2 CF3 F
240 E-CH3-CH2=CH CF3 F
241 CH2=CH-(CH2)2 CF3 F 242 E-CH3-CH2=CH-CH2 CF3 F
243 E-CH3-CH2-CH2=CH CF3 F
244 CH3 CF3 CF3
245 C2H5 CF3 CF3
Figure imgf000073_0006
247 π-C4H9 CF3 CF3
248 n-C5Hιι CF3 CF3 No. R 1 to R13 γ11 Y12 Phases (T/°C) 249 A7-C6H i3 CF3 CF3
Figure imgf000074_0001
251 n-C8H17 CF3 CF3
Figure imgf000074_0002
253 CH2=CH CF3 CF3 254 CH2=CH-CH2 CF3 CF3 255 E-CH3-CH2=CH CF3 CF3
Figure imgf000074_0003
257 E-CH3-CH2=CH-CH2 CF3 CF3 258 E-CH3-CH2-CH2= =CH CF3 CF3
Example 259 to 348
Analogously to Example 1 the following compounds are prepared:
Figure imgf000074_0004
259 CH3 H H 260 C2H5 H H 261 n-C3H7 H H Tg -5°C C 79°C l 262 f7-C4H9 H H
Figure imgf000074_0005
264 n-C6H i3 H H 265 A?-C7H15 H H
Figure imgf000074_0006
267 n-CgH g H H 268 CH2=CH H H 269 CH2=CH-CH2 H H 270 E-CH3-CH2=CH H H 271 CH2=CH-(CH2)2 H H 272 E-CH3-CH2=CH-CH2 H H No. R11 to R13 γ11 γ12 Phases (T/°C)
273 E-CH3-CH2-CH2=CH H H
274 CH3 F H
275 C2H5 F H
276 t?-C3H7 F H
277 A7-C4H9 F H
278 n-C5Hn F H
279 A -C6H 13 F H
Figure imgf000075_0001
281 π-C8H17 F H
Figure imgf000075_0002
283 CH2=CH F H
284 CH2=CH-CH2 F H
285 E-CH3-CH2=CH F H
286 CH2=CH-(CH2)2 F H
287 E-CH3-CH2=CH-CH2 F H
288 E-CH3-CH2-CH2=CH F H
289 CH3 CF3 H
290 C2H5 CF3 H
Figure imgf000075_0003
292 /7-C4H9 CF3 H
293 π-C5Hn CF3 H
294 π-C6H i3 CF3 H
Figure imgf000075_0004
296 /?-C8H17 CF3 H
297 A7-C9H19 CF3 H
298 CH2=CH CF3 H
299 CH2=CH-CH2 CF3 H
300 E-CH3-CH2=CH CF3 H
301 CH2=CH-(CH2)2 CF3 H
302 E-CH3-CH2=CH-CH2 CF3 H
303 E-CH3-CH2-CH2=CH CF3 H
304 CH3 F F
305 C2H5 F F
306 A7-C3H7 F F Tg -22°C I
307 A7-C4Hg F F No. R 1"1 to R ι13 Y 11 Y 12 Phases (T/°C)
Figure imgf000076_0001
309 n-C6H 13 F F
Figure imgf000076_0002
312 n-CgHig F F
313 CH2=CH F F
314 CH2=CH-CH2 F F
315 E-CH3-CH2=CH F F 316 CH2=CH-(CH2)2 F F
317 E-CH3-CH2=CH-CH2 F F
318 E-CH3-CH2-CH2=CH F F
319 CH3 CF3 F
320 C2H5 CF3 F 321 π-C3H7 CF3 F
322 n-C4H9 CF3 F
323 n-C5Hn CF3 F
324 n-C6H i3 CF3 F
325 π-C75 CF3 F
Figure imgf000076_0003
327 n-CgHig CF3 F
328 CH2=CH CF3 F
329 CH2=CH-CH2 CF3 F
330 E-CH3-CH2=CH CF3 F 331 CH2=CH-(CH2)2 CF3 F
332 E-CH3-CH2=CH-CH2 CF3 F
333 E-CH3-CH2-CH2=CH CF3 F
334 CH3 CF3 CF3
335 C2H5 CF3 CF3 336 />C3H7 CF3 CF3
337 π-C4H9 CF3 CF3
338 π-C5Hn CF3 CF3
339 7-C6H 13 CF3 CF3
340 /7-C7H15 CF3 CF3
Figure imgf000076_0004
342 n-CgHig CF3 CF3 No. R11 to R13 γ11 γ12 Phases (T/°C) 343 CH2=CH CF3 CF3 344 CH2=CH-CH2 CF3 CF3 345 E-CH3-CH2=CH CF3 CF3 346 CH2=CH-(CH2)2 CF3 CF3 347 E-CH3-CH2=CH-CH2 CF3 CF3 348 E-CH3-CH2-CH2= =CH CF3 CF3
Example 349 to 393
Analogously to Example 1 the following compounds are prepared:
Figure imgf000077_0001
No. R 1 to R13 γ11 Y12 Phases (T/°C)
349 CH3 CF3 H
350 C2H5 CF3 H
Figure imgf000077_0002
352 /7-C4H9 CF3 H
353 π-C5Hn CF3 H
354 n-C6H i3 CF3 H
Figure imgf000077_0003
356 f?-C8H17 CF3 H
357 /7-CgHig CF3 H
358 CH2=CH CF3 H
359 CH2=CH-CH2 CF3 H
360 E-CH3-CH2=CH CF3 H
361 CH2=CH-(CH2)2 CF3 H
362 E-CH3-CH2=CH-CH2 CF3 H
363 E-CH3-CH2-CH2= =CH CF3 H
364 CH3 CF3 F
Figure imgf000077_0004
366 n-C3H7 CF3 F No. R11 to R13 γ11 γ12 Phases (T/°C)
Figure imgf000078_0001
369 7-C6H i3 CF3 F
Figure imgf000078_0002
372 A7-CgHιg CF3 F
373 CH2=CH CF3 F
Figure imgf000078_0003
377 E-CH3-CH2=CH-CH2 CF3 F
378 E-CH3-CH2-CH2=CH CF3 F
Figure imgf000078_0004
390 E-CH3-CH2=CH CF3 CF3
391 CH2=CH-(CH2)2 CF3 CF3
392 E-CH3-CH2=CH-CH2 CF3 CF3
393 E-CH3-CH2-CH2=CH CF3 CF3 Examples 394 to 471
Analogously to example 1 the following compounds were prepared:
Ex. # Structure of Compound Properties
Figure imgf000079_0001
Ex. # Structure of Compound Properties
Figure imgf000080_0001
Ex. # Structure of Compound Properties
Figure imgf000081_0001
Ex. # Structure of Compound Properties
Figure imgf000082_0001
Figure imgf000082_0002
Figure imgf000082_0003
Ex. # Structure of Compound Properties
Figure imgf000083_0001
Figure imgf000083_0002
Ex. # Structure of Compound Properties
Figure imgf000084_0001
Ex. # Structure of Compound Properties
Figure imgf000085_0001
Ex. # Structure of Compound Properties
Figure imgf000086_0001
Ex. # Structure of Compound Properties
Figure imgf000087_0001
Figure imgf000087_0002
Ex. # Structure of Compound Properties
Figure imgf000088_0001
Ex. # Structure of Compound Properties
Figure imgf000089_0001
Ex. # Structure of Compound Properties
Figure imgf000090_0001
Ex. # Structure of Compound Properties
Figure imgf000091_0001
Ex. # Structure of Compound Properties
Figure imgf000092_0001
Ex. # Structure of Compound Properties
Figure imgf000093_0001
Remarks: Δn and Δε extrapolated from 10 % solution in ZLl-4792 and HTP in MLC-6260, both mixtures from Merck KGaA, all data except transition temperatures given at 20°C.
Use-Examples
Use-Example 1
A liquid crystal mixture, host mixture A, is realised consisting of:
Figure imgf000094_0001
This mixture has the following properties:
Clearing point (T(N,I))/°C: 56.8
To 85.0% of this mixture 5% of the chiral dopant R-5011 and 10% of the compound of interest are added and the properties of the resulting mixture are determined.
The data are compiled in table 1.
Tg, T (K,l) and T(g,l) given in Tables 1a, 1b below are determined by means of DSC (differential scanning calorimetry) and microscopy.
Further electro-optical data given in the tables below are measured in a test cell as described hereinafter: This test cell is an electro-optical cell with interdigital electrodes having a distance of electrodes of 10 μm, a width of electrodes of 10 μm, and a cell thickness of 10 μm. The height of the electrodes - that are made out of chromium and without a polyimid layer - can be ignored in comparison to the cell thickness. Experimental values are determined by using the standard apparatus as used in
DE 102 41 301.0.
Ttrans is the characteristic temperature which is defined as follows: - If the characteristic voltage as a function of temperature has a minimum, the temperature at this minimum is denoted as characteristic temperature; - If the characteristic voltage as a function of temperature has no minimum and if the controlling medium has one or more blue phases, the transistion temperature to the blue phase is denoted as characteristic temperature; in case there are more than one blue phase, the lowest transition temperature to a blue phase is denoted as characteristic temperature; - If the characteristic voltage as a function of temperature has no minimum and if the controlling medium has no blue phase, the transistion temperature to the isotropic phase is denoted as characteristic temperature.
In this context the term "characteristic voltage" refers to a specific voltage, e.g. the threshold voltage V10 at which a light transmission of 10% is observed or the saturation voltage Vg0 at which a transmission of 90% is observed.
^(T + 2) dV * T trans dT V(Tlrans + 2)
In each case 10 % of the respective compound of interest have been dissolved together with 5 % of the chiral dopant R-5011 in the host mixture A, both available from Merck KGaA, Germany.
The results are shown in the following tables (Tables 1a to 1w). Table 1a
Figure imgf000096_0001
Table 1c
Figure imgf000097_0001
Remarks: n.d.: not determined. Table 1f
Figure imgf000098_0001
Remarks: n.d.: not determined. Table 1i
Figure imgf000099_0001
Remarks: n.d.: not determined. Table 11
Figure imgf000100_0001
Remarks: n.d.: not determined. Table 1o
Figure imgf000101_0001
Remarks: n.d.: not determined. Table 1r
Figure imgf000102_0001
Remarks: n.d.: not determined. Table 1u
Figure imgf000103_0001
Remarks: n.d.: not determined. Use-example 2
To the host mixture A various concentrations of the compound of example 47 (also abbreviated as (P(O3)2UQU-3O-T) are added.
The concentration of the compound of example 47 in the host mixture A is varied from 3% over 5% and 7% to 15% The data are compiled in table 2.
Table 2
Figure imgf000104_0001
Remarks: Ttrans. is the transition temperature from the cholesteric phase into the optically isotropic phase. It can be observed in electro-optical cells with cross-polarisers.
There is no marked range with a flat dependency of the characteristic voltages on the temperature, however there is a marked decrease of the temperature dependency compared to the medium without the inventive compound.
Use-example 3
To the host mixture A various concentrations of the compound of example 47 (P(O3)2UQU-3O-T) are added in combination with various concentrations of the chiral dopant R-5011 available from Merck KGaA. The concentrations and the data are compiled in table 3. Table 3
Figure imgf000105_0001
In these systems a blue phase is observed and the temperature dependence of the characteristic voltages is dramatically reduced, in fact, an extended range of temperatures with a flat temperature dependence is obtained.
Use-example 4
A liquid crystal mixture, host mixture B, is realised consisting of:
Figure imgf000106_0001
This mixture has the following properties:
Clearing point (T(N,I))/°C: 22.5
To 85.0% of this mixture, host mixture B, 15% of the compound of example 47 (P(O3)2UQU-3O-T) is added and the properties of the resulting mixture are determined. The concentrations and the data are compiled in table 4.
There is no marked range with a flat dependency of the characteristic voltages on the temperature, however there is a marked decrease of the temperature dependency compared to the medium without the inventive compound. Table 4
Figure imgf000107_0001
Use-example 5
A liquid crystal mixture, host mixture C, is realised consisting of:
Figure imgf000107_0002
This mixture has the following properties:
Clearing point (T(N,I))/°C: 60.2 To 90% of this mixture, host mixture C, 5% of the compound of example 47 (P(O3)2UQU-3O-T) and 5% of the chiral dopant R-5011 are added and the properties of the resulting mixture are determined. The concentrations and the data are compiled in table 5.
Table 5
Figure imgf000108_0001
In these systems a blue phase is observed and the temperature dependence of the characteristic voltages is dramatically reduced, in fact, an extended range of temperatures with a flat temperature dependence is obtained.
Use-example 6
(The physical parameters given in the use-examples 6 to 8 are determined according to "Merck Liquid Crystals, Physical Properties of Liquid Crystals", Status Nov. 1997, Merck KGaA, Germany)
A liquid crystal mixture is realised consisting which has the following composition and properties. Table 6
Figure imgf000109_0001
Use-example 7
A liquid crystal mixture is realised, which has the following composition and properties.
Table 7
Figure imgf000110_0001
Use-example 8
A liquid crystal mixture is realised, which has the following composition and properties.
Table 8
Figure imgf000111_0001
Use-example 9
A liquid crystal mixture, host mixture D, is realised consisting of:
Figure imgf000111_0002
This mixture has the following properties:
Clearing point (T(N,I))/°C: 99.0.
Use-example 9.1
To this mixture, host mixture D, 10% of the compound of example 47 (P(O3)2UQU-3O-T) and 5% of the chiral dopant R-5011 are added, as shown in the following table, table 9, and the properties of the resulting mixture are determined. The results are compiled in table 9.
Use-example 9.2
To the same mixture, host mixture D, now 5% of the compound of example 47 (P(O3)2UQU-3O-T), and 5% of the chiral dopant R-5011 and 2% of its enantiomer S-5011 (equivalent to the addition of 3% of R-5011 and 4% of the racemate) are added, as shown in the following table, table 9, and the properties of the resulting mixture are determined. The results are compiled in table 9.
Table 9
Figure imgf000112_0001
Use-example 10
Use-examples 10.1 and 10.2
To 85%, respectively 84%, of the host mixture D, used in example 9, 10% of the compound of example 1 (P(O3)2UQU-3O-F) and the chiral dopant R-5011 is added in a concentration of 5% (Use-example 10.1), respectively of 4% (Use-example 10.2), and the properties of the resulting mixture are determined. The concentrations and the data are compiled in table 10.
Table 10
Figure imgf000113_0001
Use-example 11
Use-example 11.1
To 85% of the host mixture D, used in Use-examples 9 and 10, 10% of the compound of example 3 (P(O6)2UQU-6O-F) and 5% of the chiral dopant R-5011 are added and the properties of the resulting mixture are determined. The concentrations and the data are compiled in table 11. Table 11
Figure imgf000114_0001
Use-example 11.2
A liquid crystal mixture, host mixture E, is realised consisting of:
Figure imgf000114_0002
To 83% of this mixture, host mixture E, 4% of the compound of example 3 (P(O6)2UQU-6O-F) and 13% of the chiral dopant R-5011 are added and the properties of the resulting mixture are determined. The concentrations and the data are compiled in table 11.
Use-example 12
To 85% of the host mixture D, used in use-examples 0, 10 and 11.1, 10% of the compound of example 408 (P(O3)2PQU-3O-F) and 5% of the chiral dopant R-5011 are added and the properties of the resulting mixture are determined. The concentrations and the data are compiled in table 12.
Table 12
Figure imgf000115_0001
Use-example 13
A liquid crystal mixture, host mixture F, is realised consisting of:
Figure imgf000116_0001
Use-examples 13.1 to 13.7
To this mixture, host mixture F, various concentrations of the compound of example 47 (P(O3)2UQU-3O-T) and various concentrations of the chiral dopant R-5011 are added and the properties of the resulting mixtures are determined. The concentrations and the data are compiled in tables 13a and13b.
Table 13a
Figure imgf000116_0002
Table 13b
Figure imgf000117_0001
Use-example 14
A liquid crystal mixture, host mixture G, is realised consisting of:
Figure imgf000117_0002
This mixture has the following properties: Clearing point (T(N,I))/°C: 75.0.
Use-examples 14.1 and 14.2
To this mixture, host mixture G, alternatively 5% (use-example 14.1), 7% (use-example 14.2), and 10% (use-example 14.3), respectively, of the compound of example 47 (P(O3)2UQU-3O-T) and 5% of the chiral dopant R-5011 are added and the properties of the resulting mixtures are determined. The concentrations and the data are compiled in table 14.
Table 14
Figure imgf000118_0001
Use-example15
Use-examples 15.1 to 15.3
Three different liquid crystal mixtures, host mixtures H to I, are realised consisting of:
Figure imgf000119_0001
Figure imgf000119_0002
To each one of these mixtures, host mixtures H to K, the compound of example 47 (P(O3)2UQU-3O-T) is addded together with the chiral dopant R-5011 in the concentrations given in table 15 and the properties of the resulting mixtures are determined. The results are compiled in table 15, too.
Table 15
Figure imgf000120_0001
Use-example 16
A liquid crystal mixture, host mixture K, is realised consisting of:
Figure imgf000120_0002
To this mixture, host mixture K, 5% of the compound of example 47 (P(O3)2UQU-3O-T) is addded together with 9% of the chiral dopant BO2C*H-C-5 (which is a homologue of S-5011 (also: BO2C*H-C-3) with an n-pentyl terminal chain instead of an n-propyl group and which has an HTP in MLC-6260, available from Merck KGaA, at 20°C of -71.7 μm"1) and the property of the resulting mixture is determined. The results are compiled in table 16.
Table 16
Figure imgf000121_0001
Use-example 17
A liquid crystal mixture, host mixture L, which is similar to host mixture H used in use-example 15.1 , is realised consisting of:
Figure imgf000122_0001
To this mixture, host mixture L, 10% of the compound of example 47 (P(O3)2UQU-3O-T) is addded together with 5 of the chiral dopant R-5011 and the property of the resulting mixture is determined. The results are compiled in table 17.
Table 17
Figure imgf000122_0002

Claims

Claims
1. Liquid crystal medium, characterised in that it comprises a strongly dielectrically positive liquid crystal component A, which comprises one or more compounds of formula I
Figure imgf000123_0001
wherein a, b, c and d are independently of each other 0, 1 or 2, whereby a + b + c + d < 4;
R 11 is hydrogen, an alkyl or alkoxy radical having from 1 to 15 carbon atoms, wherein one or more methylene groups of said alkyl or alkoxy radical may be replaced independently of each other by -O-, -S-, -SiRxRy-, -CH=CH-, -C≡C-, -CO-O- and/or -O-CO- such that oxygen and/or sulfur atoms are not linked directly to each other, said alkyl or alkoxy radical being unsubstituted or mono- substituted with a -CN group or mono- or poly- substituted with halogen; or aryl, aryloxy, alkylaryl, alkylaryloxy, alkylarylalkyl, alkylarylalkoxy, cycloalkyl, cycloalkyloxy, cycloalkylalkenyloxy, alkylcycloalkyl, alkylcycloalkyloxy or alkylcycloalkylalkenyloxy, each with up to 15 carbon atoms, wherin said in radicals being unsubstituted or mono-substituted with a -CN group or mono- or poly-substituted with halogen one ore more =CH- groups may be replaced independently of each other by =N- and/or one more -CH2- groups may be replaced independently of each other by -O-, -S-, -SiRxRy-, -CH=CH-, -C≡C-, -CO-O- and/or -O-CO- such that nitrogen and oxygen and/or sulfur atoms are not linked directly to each other; L11, L12, L13 and L14 are, independently of each other, hydrogen, an alkyl or alkoxy radical having from 1 to 15 carbon atoms, wherein one or more methylene groups of said alkyl or alkoxy radical may be replaced independently of each other by -O-, -S-, -SiRxRy-, -CH=CH-, -C≡C-, -CO-O- and/or -O-CO- such that oxygen and/or sulfur atoms are not linked directly to each other, said alkyl or alkoxy radical being unsubstituted or mono-substituted with a -CN group or mono- or poly-substituted with halogen; or aryl, aryloxy, alkylaryl, alkylaryloxy, alkylarylalkyl, alkylarylalkόxy, cycloalkyl, cycloalkyloxy, cycloalkylalkenyloxy, alkylcycloalkyl, alkylcycloalkyloxy or alkylcycloalkylalkenyloxy, each with up to 15 carbon atoms, wherin said in radicals being unsubstituted or mono-substituted with a -CN group or mono- or poly-substituted with halogen one ore more =CH- groups may be replaced independently of each other by =N- and/or one more -CH2- groups may be replaced independently of each other by -O-, -S-, -SiRxRy-, -CH=CH-, -C≡C-, -CO-O- and/or -O-CO- such that nitrogen and oxygen and/or sulfur atoms are not linked directly to each other, whereby L13 and L14 are hydrogen, if at least one of L11 and L12 is not hydrogen; L11 and L12 are hydrogen, if at least one of L13 and L14 is not hydrogen; at least one of L11, L12, L13 and L14 is not hydrogen; and L11 and L12 are not halogen at the same time; X11 is H, halogen, -CN, -NCS, -SF5, -S-Rz, -SO2-R2, an alkyl or alkoxy radical having from 1 to 15 carbon atoms, wherein one or more methylene groups of said alkyl or alkoxy radical may be replaced independently of each other by -O-, -S-, -SiRxRy-, -CH=CH-, -C≡C-, -CO-O- and/or -O-CO- such that oxygen and/or sulfur atoms are not linked directly to each other, said alkyl or alkoxy radical being unsubstituted or mono-substituted with a -CN group or mono- or poly-substituted with halogen; or aryl, aryloxy, alkylaryl, alkylaryloxy, alkylarylalkyl, alkylarylalkoxy, cycloalkyl, cycloalkyloxy, cycloalkylalkenyloxy, alkylcycloalkyl, alkylcycloalkyloxy or alkylcycloalkylalkenyloxy, each with up to 15 carbon atoms, wherin said in radicals being unsubstituted or mono-substituted with a -CN group or mono- or poly-substituted with halogen one ore more =CH- groups may be replaced independently of each other by =N- and/or one more -CH2- groups may be replaced independently of each other by -O-, -S-, -SiRxRy-, -CH=CH-, -C≡C-, -CO-O- and/or -O-CO- such that nitrogen and oxygen and/or sulfur atoms are not linked directly to each other; Rx and Ry are independently of each other hydrogen or an alkyl radical having from 1 to 7 carbon atoms; Rz is an alkyl radical having from 1 to 7 carbon atoms, said alkyl radical being unsubstituted or mono- or poly-substituted with halogen; A11, A12, A13 and A14 are independently of each other a ring of one of the following formulas:
Figure imgf000125_0001
Figure imgf000126_0001
different rings if present more than once;
Y11, Y12 Y13 and Y14 are independently of each other hydrogen, halogen, an alkyl or alkoxy radical having from 1 to 15 carbon atoms wherein one or more methylene groups of said alkyl or alkoxy radical may be replaced independently of each other by -O-, -S-, -SiRxRy-, -CH=CH-, -C≡C-, -CO-O- and/or -O-CO- such that oxygen and/or sulfur atoms are not linked directly to each other, said alkyl or alkoxy radical being unsubstituted or mono- or poly- substituted with halogen; or aryl, aryloxy, alkylaryl, alkylaryloxy, alkylarylalkyl, alkylarylalkoxy, cycloalkyl, cycloalkyloxy, cycloalkylalkenyloxy, alkylcycloalkyl, alkylcycloalkyloxy or alkylcycloalkylalkenyloxy, each with up to 15 carbon atoms, wherin said in radicals being unsubstituted or mono-substituted with a -CN group or mono- or poly-substituted with halogen one ore more =CH- groups may be replaced independently of each other by =N- and/or one more -GH2- groups may be replaced independently of each other by -O-, -S-, -SiRxRy-, -CH=CH-, -C≡C-, -CO-O- and/or -O-CO- such that nitrogen and oxygen and/or sulfur atoms are not linked directly to each other; f, g, h and j are independently of each other 0, 1 , 2 or 3;
Z11, Z12, Z 3 and Z14 are independently of each other a single bond, -CH2CH -,(-CH2CH2-)2, -CF2-CF2-, -CF2-CH -, -CH2-CF2-, -CH=CH-, -CF=CF-, -CF=CH-, -CH=CF-, -C≡C-, -CH2O-, -OCH2-, -CF2O-, -OCF2-, -CO-O- or -O-CO- whereby each of Z11, Z12, Z13 and Z14 may have the same or a different meaning if present more than once.
2. Liquid crystal medium according to claim 1 , characterised in that, it comprises one or more compounds of formula 1-1
Figure imgf000127_0001
wherein the parameters have the meaning given in claim 1.
3. Liquid crystal medium according to claim 2, characterised in that, it comprises one or more compounds of formula 1-1 given in claim 2 wherein R11, R12 and R13 , independently of each other, are n-alkyl or n- alkoxy with 1 to 20 C-atoms, alkenyl, alkenyloxy or alkoxyalkyl with 2 to 20 C-atoms or CN, NCS, halogen, halogenated alkyl, alkenyl or alkoxy, L11, L12, Y11 and Y12 , independently of each other, are H, halogen, CN, NCS, halogenated alkyl, alkenyl or alkoxy and X11 is H, halogen or Cl, CN, NCS, SF5, -SCF3, -SO2CF3, -SO2C2F5, -SO2C4F9, halogenated alkyl, alkenyl or alkoxy.
3. Liquid crystal medium according to at least one of claims 1 and 2, characterised in that the dielectrically positive component B comprises one or more compounds of formula II
Figure imgf000128_0001
wherein n2 is 0, 1 or 2,
R2 has the meaning given for R11 under formula I in claim 1 , Z21 and Z22 , independently of each other, are a single bond, -CH2CH2-,(-CH CH2-)2, -CF2-CF2-, -CF2-CH2-, -CH -CF2- , -CH=CH-, -CF=CF-, -CF=CH-, -CH=CF-, -C≡C-, -CH2O-, -OCHz-, -CF2O-, -OCF2-, -CO-O- or -O-CO- whereby each of Z22 may have the same or a different meaning if present twice,
Figure imgf000129_0001
each, independently of each other, are
Figure imgf000129_0002
is CN, NCS, SF5, SO2CF3, CF3, OCF3, F or Cl.
4. . Compound of formula 1-1
Figure imgf000129_0003
wherein R11, R12 and R1 , independently of each other, are n-alkyl or n- alkoxy with 1 to 20 C-atoms, alkenyl, alkenyloxy or alkoxyalkyl with 2 to 20 C-atoms, or CN, NCS, halogen, halogenated alkyl, alkenyl or alkoxy, L11, L12, Y11 and Y12 , independently of each other, are H, halogen, CN, NCS, unsubstituted or halogenated alkyl, alkenyl or alkoxy, and X11 is H, halogen, CN, NCS, SF5, SO2CF3, halogenated alkyl, alkenyl or alkoxy, preferably mono-, di- or oligo-fluorinated alkyl, alkenyl or alkoxy.
5. Compound according to claim 4, characterised in that
R11, R12 and R13 , independently of each other, are n-alkyl or n- alkoxy with 1 to 7 C-atoms preferably 2 to 5 C- atoms, alkenyl, alkenyloxy or alkoxyalkyl with 2 to 7 C-atoms or CN, NCS, halogen, preferably F, Cl, halogenated alkyl, alkenyl or alkoxy, L11, L12, Y11 and Y12 , independently of each other, are H, halogen, CN, NCS, unsubstituted or halogenated alkyl, alkenyl or alkoxy, preferably mono-, di- or oligo-fluorinated alkyl, alkenyl or alkoxy and X11 is H, halogen, preferably F or Cl, CN, NCS, SF5, SO2CF3, unsubstituted or halogenated alkyl, alkenyl or alkoxy, preferably mono-, di- or oligo-fluorinated alkyl, alkenyl or alkoxy.
6. Compound according to at least one of claims 4 and 5, characterised in that R11, R12 and R13 are identical to each other.
7. Compound according to at least one of claims 4 to 6, characterised in that
R11, R12 and R13 , independently of each other, n-alkoxy with 1 to 7 C-atoms or alkenyloxy with 2 to 7 C- atoms.
8. Compound according to at least one of claims 4 to 7, characterised in that
X11 is F, Cl, CN, NCS, SF5, SO2CF3, F, CF3 or OCF3.
9. Compound according to at least one of claims 4 to 8, characterised in that at least one of L11 and L12 is F and at least one of Y11 and Y12 is F and the others are, independently of each other, H or F.
10. Liquid crystal display, characterised in that it comprises a liquid crystal medium according to at least one of claims 1 to 4 or a compound according to at least one of the claims 5 to 9.
11. Liquid crystal display according to claim 10, characterised in that it is operated or operable at a temperature at which mesogenic control medium is in an optically isotropic state.
12. Use of a liquid crystal medium according to at least one of claims 1 to 4 in an electro-optical display.
13. Use of a compound according to at least one of claims 5 to 9 in a liquid crystal mixture.
14. Use of a compound according to at least one of claims 5 to 9 in an electro-optical display.
15. Use of a liquid crystal medium according to at least one of claims 1 to 4 in an electro-optical display.
PCT/EP2004/008942 2003-08-25 2004-08-10 Mesogenic compounds, medium for electro-optical displays and electro-optical display WO2005019378A1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
AT04763959T ATE447001T1 (en) 2003-08-25 2004-08-10 MESOGENIC COMPOUNDS, MEDIUM FOR ELECTROOPTICAL DISPLAY AND ELECTROOPTICAL DISPLAY
JP2006524270A JP2007503487A (en) 2003-08-25 2004-08-10 Mesogenic compound, medium for electro-optic display and electro-optic display
DE602004023857T DE602004023857D1 (en) 2003-08-25 2004-08-10 MESOGENIC COMPOUNDS, MEDIUM FOR ELECTROOPTICAL DISPLAY AND ELECTROOPTICAL DISPLAY
EP04763959A EP1658351B1 (en) 2003-08-25 2004-08-10 Mesogenic compounds, medium for electro-optical displays and electro-optical display
KR1020067003696A KR101198452B1 (en) 2003-08-25 2004-08-10 Mesogenic compounds, medium for electro-optical displays and electro-optical display
US10/569,459 US7531106B2 (en) 2003-08-25 2004-08-10 Mesogenic compounds, medium for electro-optical displays and electro-optical display

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03018707.4 2003-08-25
EP03018707 2003-08-25

Publications (1)

Publication Number Publication Date
WO2005019378A1 true WO2005019378A1 (en) 2005-03-03

Family

ID=34203216

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2004/008942 WO2005019378A1 (en) 2003-08-25 2004-08-10 Mesogenic compounds, medium for electro-optical displays and electro-optical display

Country Status (8)

Country Link
US (1) US7531106B2 (en)
EP (1) EP1658351B1 (en)
JP (1) JP2007503487A (en)
KR (1) KR101198452B1 (en)
AT (1) ATE447001T1 (en)
DE (1) DE602004023857D1 (en)
TW (1) TWI387638B (en)
WO (1) WO2005019378A1 (en)

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005112540A2 (en) * 2004-05-21 2005-12-01 Merck Patent Gmbh Liquid crystal compounds, liquid crystal medium and liquid crystal display
US7126026B2 (en) 2003-11-13 2006-10-24 Sanofi-Aventis Deutschland Gmbh Process for preparing 4-pentafluorosulfanylbenzoylguanidines
US7317124B2 (en) 2003-11-13 2008-01-08 Sanofi-Aventis Deutschland Gmbh Ortho-substituted pentafluorosulfanylbenzenes, process for their preparation and their use as valuable synthetic intermediates
WO2008105286A1 (en) 2007-02-28 2008-09-04 Chisso Corporation Pentacyclic liquid crystal compound having cf2o bonding group, liquid crystal composition and liquid crystal display
WO2008128622A2 (en) * 2007-04-24 2008-10-30 Merck Patent Gmbh Pyridine compounds for liquid-crystalline mixtures
US7622611B2 (en) 2003-11-13 2009-11-24 Sanofi-Aventis Deutschland Gmbh Pentafluorosulfanylbenzoylguanidines, process for their preparation, use as a medicament or diagnostic aid, and medicament comprising same
JP2009541234A (en) * 2006-06-23 2009-11-26 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング Mesogenic compound, liquid crystal medium and liquid crystal display
WO2009150963A1 (en) 2008-06-09 2009-12-17 チッソ株式会社 Pentacyclic liquid crystal compound having cyclohexane ring, liquid crystal composition and liquid crystal display element
WO2010047260A1 (en) 2008-10-21 2010-04-29 チッソ株式会社 Pentacyclic liquid crystal compound having nitrogen-containing heterocyclic ring, liquid crystal composition, and liquid crystal display element
WO2011099572A1 (en) * 2010-02-12 2011-08-18 旭化成イーマテリアルズ株式会社 Fluoroalkane derivative, gelling agent and gel composition
US8003175B2 (en) 2008-06-24 2011-08-23 Jnc Corporation Liquid crystal composition and liquid crystal display device
US8110256B2 (en) 2008-06-25 2012-02-07 Jnc Corporation Liquid crystal composition and liquid crystal display device
US8399136B2 (en) 2009-02-18 2013-03-19 Asahi Kasei E-Materials Corporation Electrolyte solution for lithium ion secondary battery, lithium ion secondary battery, fluoroalkane derivative and gelling agent
US8524748B2 (en) 2008-10-08 2013-09-03 Panmira Pharmaceuticals, Llc Heteroalkyl biphenyl antagonists of prostaglandin D2 receptors
GB2478451B (en) * 2009-01-16 2014-04-09 Jnc Corp Liquid crystal compound, liquid crystal composition,and liquid crystal display device
US9118088B2 (en) 2009-06-10 2015-08-25 Asahi Kasei E-Materials Corporation Electrolyte solution and lithium ion secondary battery using the same
EP2714843B1 (en) 2011-06-01 2016-12-21 Merck Patent GmbH Liquid crystal medium and liquid crystal display device
EP3109295A1 (en) * 2015-06-22 2016-12-28 Samsung Display Co., Ltd. Compound, liquid crystal composition including the same, and liquid crystal display device including the same
FR3090317A1 (en) 2018-12-19 2020-06-26 Cvasthera USE OF A PAR-1 ANTAGONIST FOR THE TREATMENT OF CHRONIC INTESTINAL INFLAMMATORY DISEASE
CN115960074A (en) * 2022-05-27 2023-04-14 华南理工大学 Fluorine-containing ferroelectric liquid crystal molecules containing heteroatom hexatomic alicyclic ring and synthesis method thereof

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8129002B2 (en) * 2003-08-25 2012-03-06 Merck Patent Gmbh Compounds for use in liquid crystal media
JP4776279B2 (en) * 2005-06-09 2011-09-21 株式会社Adeka Novel compound and liquid crystal composition
JP2009067780A (en) * 2007-08-22 2009-04-02 Chisso Corp Liquid crystal compound having chloronaphthalene moiety, liquid crystal composition, and optical device
JP5338669B2 (en) * 2007-08-27 2013-11-13 Jnc株式会社 Liquid crystal composition and liquid crystal display element
US7879413B2 (en) * 2007-08-29 2011-02-01 Chisso Corporation Optically isotropic liquid crystal medium and optical device
KR101503949B1 (en) * 2007-08-29 2015-03-18 제이엔씨 석유 화학 주식회사 Liquid crystal composition and liquid crystal display element
CN101772560B (en) 2007-08-30 2013-03-13 Jnc株式会社 Liquid crystal composition, and liquid crystal display element
JP5577566B2 (en) 2007-08-31 2014-08-27 Jnc株式会社 Liquid crystal composition and liquid crystal element
EP2182042B1 (en) * 2007-08-31 2016-05-11 JNC Corporation Liquid crystal composition and liquid crystal display device
KR101770004B1 (en) * 2009-09-25 2017-08-21 메르크 파텐트 게엠베하 Compounds for a liquid crystal medium and high-frequency components containing said liquid crystal medium
US8168084B2 (en) * 2009-12-18 2012-05-01 Vanderbilt University Polar nematic compounds
KR20120058901A (en) * 2010-11-30 2012-06-08 주식회사 동진쎄미켐 Fast Response Bimesogenic Compound with Adjusted Dielectric Anisotropy of Both Side Mesogenic Groups
EP2568032B1 (en) * 2011-09-06 2014-11-26 Merck Patent GmbH Liquid crystal medium and liquid crystal display
WO2013114772A1 (en) * 2012-01-31 2013-08-08 Dic株式会社 Compound
CN104066815B (en) 2012-02-03 2017-03-08 捷恩智株式会社 Liquid-crystal composition and its purposes and LCD assembly
TWI570221B (en) * 2012-03-19 2017-02-11 Dainippon Ink & Chemicals Nematic liquid crystal composition
KR101555596B1 (en) 2012-08-22 2015-09-24 디아이씨 가부시끼가이샤 Nematic liquid crystal composition
WO2014034772A1 (en) * 2012-09-03 2014-03-06 Dic株式会社 Nematic liquid crystal composition
US10711196B2 (en) * 2012-12-10 2020-07-14 Merck Patent Gmbh Bimesogenic compounds and mesogenic media
CN104854217B (en) 2012-12-17 2017-06-23 捷恩智株式会社 Liquid-crystal composition, mixture, composite, liquid crystal cell and chipal compounds
JP6102423B2 (en) * 2013-03-29 2017-03-29 Dic株式会社 Polymerizable compound and optical element
JP5776864B1 (en) 2013-08-30 2015-09-09 Dic株式会社 Nematic liquid crystal composition
CN106459767B (en) 2014-07-31 2019-04-19 Dic株式会社 Nematic liquid crystal composition
CN104513665A (en) * 2014-12-31 2015-04-15 石家庄诚志永华显示材料有限公司 Liquid crystal medium containing triphenyl series compounds and application thereof
JP6578690B2 (en) * 2015-03-23 2019-09-25 Jnc株式会社 Liquid crystal compound having halogenated alkyl, liquid crystal composition, and liquid crystal display device
CN108697144A (en) * 2016-01-22 2018-10-23 利乐拉瓦尔集团及财务有限公司 Method and apparatus for hydrolyzed infant formula
WO2019089638A1 (en) * 2017-10-31 2019-05-09 The Regents Of The University Of California Organic ligands for templatable mesoscale nanocapsules
CN110655926B (en) * 2018-06-28 2023-06-13 江苏和成显示科技有限公司 Liquid crystal composition and liquid crystal display device thereof
JP6863406B2 (en) * 2019-05-27 2021-04-21 Jnc株式会社 Liquid crystal compounds, liquid crystal compositions and liquid crystal display devices with halogenated alkyl
CN113897202A (en) * 2021-11-17 2022-01-07 浙江工业大学 Difluoromethyleneoxy liquid crystal compound and synthesis method thereof
CN115627175A (en) * 2022-09-30 2023-01-20 南昌虚拟现实研究院股份有限公司 Liquid crystal composition and liquid crystal optical element

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08143498A (en) * 1994-11-17 1996-06-04 Dainippon Ink & Chem Inc 5-substituted alkoxybenzene derivative
US6177154B1 (en) * 1996-09-17 2001-01-23 Chisso Corporation Alkoxybenzene derivative, liquid-crystal composition, and liquid-crystal display element

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2962825B2 (en) * 1989-10-02 1999-10-12 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング Electro-optical liquid crystal system
US5958290A (en) * 1989-10-02 1999-09-28 Merck Patent Gesellschaft Mit Beschrankter Haftung Electrooptical liquid crystal system
DE60137810D1 (en) * 2000-02-14 2009-04-16 Merck Patent Gmbh Liquid crystal compounds, liquid crystal medium and liquid crystal display
US8129002B2 (en) * 2003-08-25 2012-03-06 Merck Patent Gmbh Compounds for use in liquid crystal media

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08143498A (en) * 1994-11-17 1996-06-04 Dainippon Ink & Chem Inc 5-substituted alkoxybenzene derivative
US6177154B1 (en) * 1996-09-17 2001-01-23 Chisso Corporation Alkoxybenzene derivative, liquid-crystal composition, and liquid-crystal display element

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BEZBORODOV V S ET AL: "SYNTHESIS AND PROPERTIES OF SOME LATERALLY SUBSTITUTED LIQUID CRYSTALS", LIQUID CRYSTALS, TAYLOR AND FRANCIS LTD, LONDON, GB, vol. 21, no. 6, 1 December 1996 (1996-12-01), pages 801 - 806, XP000639773, ISSN: 0267-8292 *
PATENT ABSTRACTS OF JAPAN vol. 1996, no. 10 31 October 1996 (1996-10-31) *

Cited By (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7449594B2 (en) 2003-11-13 2008-11-11 Sanofi-Aventis Deutschland Gmbh Process for preparing 4-pentafluorosulfanylbenzoylguanidines
US7317124B2 (en) 2003-11-13 2008-01-08 Sanofi-Aventis Deutschland Gmbh Ortho-substituted pentafluorosulfanylbenzenes, process for their preparation and their use as valuable synthetic intermediates
US7932416B2 (en) 2003-11-13 2011-04-26 Sanofi-Aventis Deutschland Gmbh Ortho-substituted pentafluorosulfanylbenzenes, process for their preparation and their use as valuable synthetic intermediates
US7659429B2 (en) 2003-11-13 2010-02-09 Sanofi-Aventis Deutschland Gmbh Process for preparing 4-pentafluorosulfanylbenzoylguanidines
US7126026B2 (en) 2003-11-13 2006-10-24 Sanofi-Aventis Deutschland Gmbh Process for preparing 4-pentafluorosulfanylbenzoylguanidines
US7622611B2 (en) 2003-11-13 2009-11-24 Sanofi-Aventis Deutschland Gmbh Pentafluorosulfanylbenzoylguanidines, process for their preparation, use as a medicament or diagnostic aid, and medicament comprising same
WO2005112540A3 (en) * 2004-05-21 2006-12-14 Merck Patent Gmbh Liquid crystal compounds, liquid crystal medium and liquid crystal display
WO2005112540A2 (en) * 2004-05-21 2005-12-01 Merck Patent Gmbh Liquid crystal compounds, liquid crystal medium and liquid crystal display
JP2009541234A (en) * 2006-06-23 2009-11-26 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング Mesogenic compound, liquid crystal medium and liquid crystal display
WO2008105286A1 (en) 2007-02-28 2008-09-04 Chisso Corporation Pentacyclic liquid crystal compound having cf2o bonding group, liquid crystal composition and liquid crystal display
US7951433B2 (en) 2007-02-28 2011-05-31 Chisso Corporation Five-ring liquid crystal compound having CF2O bonding group, liquid crystal composition, and liquid crystal display device
CN101663275B (en) * 2007-04-24 2013-01-02 默克专利股份有限公司 Pyridine compounds for liquid-crystalline mixtures
WO2008128622A2 (en) * 2007-04-24 2008-10-30 Merck Patent Gmbh Pyridine compounds for liquid-crystalline mixtures
US8012547B2 (en) 2007-04-24 2011-09-06 Merch Patent Gmbh Pyridine compounds for liquid-crystalline mixtures
WO2008128622A3 (en) * 2007-04-24 2009-01-15 Merck Patent Gmbh Pyridine compounds for liquid-crystalline mixtures
WO2009150963A1 (en) 2008-06-09 2009-12-17 チッソ株式会社 Pentacyclic liquid crystal compound having cyclohexane ring, liquid crystal composition and liquid crystal display element
US8003175B2 (en) 2008-06-24 2011-08-23 Jnc Corporation Liquid crystal composition and liquid crystal display device
US8110256B2 (en) 2008-06-25 2012-02-07 Jnc Corporation Liquid crystal composition and liquid crystal display device
US8524748B2 (en) 2008-10-08 2013-09-03 Panmira Pharmaceuticals, Llc Heteroalkyl biphenyl antagonists of prostaglandin D2 receptors
KR20110070988A (en) 2008-10-21 2011-06-27 제이엔씨 주식회사 Pentacyclic liquid crystal compound having nitrogen-containing heterocyclic ring, liquid crystal composition, and liquid crystal display element
WO2010047260A1 (en) 2008-10-21 2010-04-29 チッソ株式会社 Pentacyclic liquid crystal compound having nitrogen-containing heterocyclic ring, liquid crystal composition, and liquid crystal display element
CN102186821A (en) * 2008-10-21 2011-09-14 Jnc株式会社 Pentacyclic liquid crystal compound having nitrogen-containing heterocyclic ring, liquid crystal composition, and liquid crystal display element
GB2478451B (en) * 2009-01-16 2014-04-09 Jnc Corp Liquid crystal compound, liquid crystal composition,and liquid crystal display device
US8399136B2 (en) 2009-02-18 2013-03-19 Asahi Kasei E-Materials Corporation Electrolyte solution for lithium ion secondary battery, lithium ion secondary battery, fluoroalkane derivative and gelling agent
US9118088B2 (en) 2009-06-10 2015-08-25 Asahi Kasei E-Materials Corporation Electrolyte solution and lithium ion secondary battery using the same
WO2011099572A1 (en) * 2010-02-12 2011-08-18 旭化成イーマテリアルズ株式会社 Fluoroalkane derivative, gelling agent and gel composition
EP2714843B1 (en) 2011-06-01 2016-12-21 Merck Patent GmbH Liquid crystal medium and liquid crystal display device
US10450509B2 (en) 2011-06-01 2019-10-22 Merck Patent Gmbh Liquid crystal medium and liquid display
EP2714843B2 (en) 2011-06-01 2019-10-30 Merck Patent GmbH Liquid crystal medium and liquid crystal display device
EP3109295A1 (en) * 2015-06-22 2016-12-28 Samsung Display Co., Ltd. Compound, liquid crystal composition including the same, and liquid crystal display device including the same
US9862886B2 (en) 2015-06-22 2018-01-09 Samsung Display Co., Ltd. Compound, liquid crystal composition including the same, and liquid crystal display device including the same
FR3090317A1 (en) 2018-12-19 2020-06-26 Cvasthera USE OF A PAR-1 ANTAGONIST FOR THE TREATMENT OF CHRONIC INTESTINAL INFLAMMATORY DISEASE
CN115960074A (en) * 2022-05-27 2023-04-14 华南理工大学 Fluorine-containing ferroelectric liquid crystal molecules containing heteroatom hexatomic alicyclic ring and synthesis method thereof

Also Published As

Publication number Publication date
TW200526763A (en) 2005-08-16
KR101198452B1 (en) 2012-11-06
ATE447001T1 (en) 2009-11-15
TWI387638B (en) 2013-03-01
US20060286308A1 (en) 2006-12-21
US7531106B2 (en) 2009-05-12
EP1658351A1 (en) 2006-05-24
JP2007503487A (en) 2007-02-22
EP1658351B1 (en) 2009-10-28
DE602004023857D1 (en) 2009-12-10
KR20060119877A (en) 2006-11-24

Similar Documents

Publication Publication Date Title
WO2005019378A1 (en) Mesogenic compounds, medium for electro-optical displays and electro-optical display
KR101435761B1 (en) Liquid crystal system and liquid crystal display
KR101198471B1 (en) Compounds for use in liquid crystal media
KR101986858B1 (en) Liquid crystal medium and liquid crystal display
KR101770833B1 (en) Liquid crystalline medium and liquid crystal display
KR101198479B1 (en) Liquid crystalline medium
KR101983867B1 (en) Liquid crystal medium and liquid crystal display
GB2387603A (en) Liquid crystalline medium and liquid crystal display
KR20130027079A (en) Liquid crystal media and liquid crystal display
KR20160105484A (en) Liquid crystal medium and liquid crystal display
KR20150067263A (en) Liquid crystal medium and liquid crystal display
KR20150002847A (en) Liquid crystal medium and liquid crystal display
KR20150144787A (en) Mesogenic compound, liquid crystal medium and liquid crystal display
KR20170038058A (en) Polymerisable mesogenic compound, liquid crystal medium and liquid crystal display
KR101980926B1 (en) Liquid crystal medium and liquid crystal display
KR101570543B1 (en) Mesogenic compounds liquid crystal medium and liquid crystal display
WO2021004868A1 (en) Liquid-crystalline medium and liquid-crystal display comprising the same and compounds
KR20180030701A (en) Liquid crystal medium and liquid crystal display
WO2024017812A1 (en) Liquid crystalline medium
EP3124573B1 (en) Liquid crystal medium and liquid crystal display
WO2023180505A1 (en) Liquid crystalline medium

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2004763959

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 1020067003696

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 2006286308

Country of ref document: US

Ref document number: 2006524270

Country of ref document: JP

Ref document number: 10569459

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2004763959

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1020067003696

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 10569459

Country of ref document: US